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ABSTRACT 
 
Genetic association studies have successfully identified many genetic markers associated 
with complex human diseases and related quantitative traits. However, for most complex 
diseases and quantitative traits, all associated genetic markers identified to date only 
explain a small proportion of heritability. Thus, exploring the unexplained heritability in 
these traits will help us discover novel genetic determinants for these traits and better 
understand disease etiology and pathophysiology. Due to limited sample size, a single 
cohort study may not have sufficient power to identify novel genetic association with a 
small effect size, and meta-analysis approaches have been proposed and applied to 
combine results from multiple cohorts in large consortia, increasing the sample size and 
statistical power. Rare genetic variants and gene by environment interaction may both 
play a role in genetic association studies. In this dissertation, we develop statistical 
methods in meta-analysis, rare genetic variants analysis and gene by environment 
interaction analysis, conduct extensive simulation studies, and apply these methods in 
 vii 
 
real data examples. First, we develop a method of moments estimator for the between-
study covariance matrix in random effects model multivariate meta-analysis. Our 
estimator is the first such estimator in matrix form, and holds the invariance property to 
linear transformations. It has similar performance with existing methods in simulation 
studies and real data analysis. Next, we extend the Sequence Kernel Association Test 
(SKAT), a rare genetic variants analysis approach for unrelated individuals, to be 
applicable in family samples for quantitative traits. The extension is necessary, as the 
original test has inflated type I error when directly applied to related individuals, and 
selecting an unrelated subset from family samples reduces the sample size and power. 
Finally, we derive methods for rare genetic variants analysis in detecting gene by 
environment interaction on quantitative traits, in the context of univariate test on the 
interaction term parameter. We develop statistical tests in the settings of both burden test 
and SKAT, for both unrelated and related individuals. Our methods are relevant to 
genetic association studies, and we hope that they can facilitate research in this field and 
beyond. 
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Chapter 1 Introduction 
 
1.1   Genetic Association Studies 
Genetic association studies, including genome-wide association studies (GWAS) and 
candidate gene studies, have been widely used to identify genetic markers associated with 
complex diseases or disease-related quantitative traits. In GWAS, investigators are 
usually interested in biallelic common genetic variants, defined as genetic markers with 
minor allele frequency (MAF) greater than 5% or 1%, using a single marker test such as 
logistic regression or linear regression. In recent years, a large number of genetic markers 
associated with complex diseases and related quantitative traits have been identified by 
GWAS. However, they only explain a small proportion of heritability in these traits, and 
different strategies for exploring the unexplained heritability are of great interest in this 
field [Eichler et al., 2010]. 
 
One reason is that the sample size of a single cohort or case-control study is not large 
enough to detect association with genetic variants with smaller effect sizes. As the sample 
size increases, genetic variants with weaker association can be found due to increased 
power [McCarthy et al., 2008]. Thus, consortia have been formed to unite multiple 
cohorts or case-control studies [Zeggini et al., 2008; Psaty et al., 2009]. Investigators 
conduct association analysis separately and combine their study results via meta-analysis, 
and they have identified a lot of novel genetic variants associated with different traits 
[Dupuis et al., 2010; Lindgren et al., 2009; Prokopenko et al., 2009]. Lin and Zeng [2010] 
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showed that meta-analysis does not have compromised power compared with combining 
individual data. Thus, collaborating with other cohorts to increase the sample size by 
meta-analysis is one possible way to explore the unexplained heritability. 
 
On the other hand, the single marker test in GWAS is not powerful in detecting the 
association with rare genetic variants. However, there are a lot more rare genetic variants 
than common genetic variants in the human genome, and they may explain some of the 
unexplained heritability. With the advances in sequencing technology and decreasing cost, 
rare genetic variants data have become available in many cohorts. As an emerging field 
in genetic association studies, rare genetic variants analysis has become of great interest 
in recent years. 
 
Genetic markers are not the only determinant for complex diseases or disease-related 
quantitative traits. Epidemiological studies have identified the association between 
diseases and environmental variables. Thus, it is reasonable to hypothesize that 
environmental variables may interact with genetic markers on the traits. Statistical 
approaches for detecting gene by environment interaction have been proposed for single 
cohort [Kraft et al., 2007], and also in the meta-analysis context [Manning et al., 2011]. 
They have been widely used to identify novel association and to help explore the 
unexplained heritability [Manning et al., 2012]. 
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1.2   Genetic Association Studies in Family Samples 
Family-based study designs have a long history in linkage analysis of diseases and 
quantitative traits [Falk and Rubinstein, 1987; Ott, 1989; Terwilliger and Ott, 1992; 
Spielman, McGinnis and Ewens, 1993]. However, in GWAS era, researchers have 
become more interested in unrelated individuals in genetic association studies. For family 
samples, ordinary regression approaches are not directly applicable, because inflated type 
I error is observed when familial correlation is not appropriately modeled. A simple way 
to solve this issue, selecting unrelated individuals from family samples, usually leads to 
great power loss due to reduced sample size. 
 
Statistical approaches have been proposed to analyze correlated data. In the GWAS 
context, for quantitative traits, linear mixed effects models that take familial correlation 
as a random effect with covariance proportional to the kinship matrix is commonly used 
for single marker tests [Amos, 1994; Almasy and Blangero, 1998; Pankratz, de Andrade 
and Therneau, 2005]. For dichotomous traits, generalized estimating equations [Liang 
and Zeger, 1986] are usually applied in genetic association studies to analyze family data. 
 
1.3   Meta-Analysis 
Meta-analysis is a general approach to combine evidence from multiple studies to make 
inference about one or more effect sizes of interest. Meta-analysis methods include p-
value based approaches and effect size based approaches. For p-value based approaches, 
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the p-values from all   studies            are combined into an overall p-value. 
Fisher [Fisher, 1925] proposed using the statistic 
           
 
   
   
Under the null hypothesis, all    should follow a uniform distribution on the interval (0, 
1), and are independent provided that the samples do not overlap between studies. Thus 
   follows a chi-square distribution with    degrees of freedom. Alternatively, we can 
use Stouffer’s method [Stouffer et al., 1949], resulting in the test statistic 
   
 
  
        
 
   
   
where   is the cumulative distribution function of standard normal distribution. Under 
the null hypothesis,    follows a standard normal distribution. 
 
The major drawback of p-value based approaches is that they do not take the direction of 
association into consideration. A weighted signed Z-score approach [Lipták, 1958] 
converts the p-value    from each study to a standard normal statistic    with the sign 
reflecting the direction of association, and calculates the test statistic 
   
      
 
   
    
 
   
   
where    is the sample size in study  . Under the null hypothesis,    also follows a 
standard normal distribution. However, we cannot get a summary effect size estimate 
using the three methods discussed above. 
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Depending on the number of effect sizes of interest, effect size based approaches can be 
categorized into univariate meta-analysis and multivariate meta-analysis. In both cases, 
inverse variance (or covariance matrix) weighted meta-analysis using fixed effects model 
and random effects model have been proposed. The validity of the fixed effects model 
meta-analysis depends on the underlying assumption that all studies in the meta-analysis 
share the same effect size. In the presence of heterogeneity, the fixed effects model 
incorrectly ignores the between-study variance (or covariance matrix) and may yield false 
positive results. The random effects model takes into account both within-study and 
between-study variances (or covariance matrices). It is more conservative than the fixed 
effects model and should be favored in the presence of heterogeneity. 
 
In the univariate case, we use the effect estimate    and its standard error        from 
each study and calculate the fixed effects model summary effect estimate 
    
 
  
       
 
   
 
 
       
 
   
   
with standard error 
        
 
  
 
       
 
   
   
We can also perform the random effects model meta-analysis by calculating the summary 
effect estimate 
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with standard error 
        
 
  
 
           
 
   
   
where the between-study variance estimate     is estimated using the restricted maximum 
likelihood (REML) method, the expectation-maximization (EM) algorithm [Dempster, 
Laird and Rubin, 1977], DerSimonian and Laird’s [1986] method of moments, or other 
approaches. 
 
In the context of multivariate meta-analysis, we use the effect estimate    and its 
covariance matrix estimate         from each study and calculate the fixed effects 
model summary effect estimate 
             
  
 
   
 
  
         
    
 
   
    
with covariance matrix estimate 
                  
  
 
   
 
  
   
If we perform a random effects model multivariate meta-analysis, we first get an estimate 
for the between-study covariance matrix   , then we can calculate the summary effect 
estimate 
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with covariance matrix estimate 
                       
  
 
   
 
  
   
The fixed effects model is more widely used than the random effects model in 
multivariate meta-analysis, possibly due to the difficulty in estimating the between-study 
covariance matrix. 
 
1.4   Rare Genetic Variants Analysis 
When analyzing rare genetic variants, the single marker test, which is typically used for 
common genetic variants analysis in GWAS, is not powerful. Supposing that we have   
rare genetic variants in a genomic region, the multivariate test in a regression framework 
is also not ideal because of the large number ( ) of parameters. To jointly analyze 
multiple rare genetic variants and to reduce the number of parameters, various burden 
tests have been proposed [Li and Leal, 2008; Morgenthaler and Thilly, 2007; Madsen and 
Browning, 2009; Morris and Zeggini, 2010]. These tests first calculate the combined 
genetic score for all rare genetic variants, and then perform a univariate test on the 
combined genotype score. We can simply use an indicator of any rare variants, calculate 
the total number (or proportion) of rare alleles, or use a weighted sum. Burden tests are 
most powerful when all rare genetic variants in the test share the same direction of effects, 
or even have the same effect size. If there are both protective and detrimental rare genetic 
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variants in the test, the effects would cancel out, which significantly decreases the power 
of burden tests. 
 
Li and Leal [2008] proposed a compromise between burden tests and multivariate tests. 
Their approach, named combined multivariate and collapsing (CMC) method, divides the 
genetic variants analyzed into several categories based on the MAF spectra and assesses 
association between the trait and multiple combined genotype scores. The CMC method 
performs better than burden tests in certain scenarios because it allows different genotype 
scores to have different directions of effects. However, it works best when all genetic 
variants in each category share the same direction of effects, which may not be true in 
practice. 
 
Han and Pan [2010] proposed a data-adaptive sum test which does not make any 
assumption on the direction of effects. Instead, it first performs single marker tests on all 
rare genetic variants analyzed and then calculates the combined genotype score using the 
signs from single marker tests. Hoffman, Marini and Witte [2010] developed a step-up 
approach which not only takes the signs, but also incorporates weights. However, since 
both methods use data-driven information in the test, they require permutation to 
calculate p-values. 
 
Wu et al. [2011] proposed the sequence kernel association test (SKAT) as a non-
collapsing method in rare genetic variants analysis. It does not make any assumptions on 
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the direction of effects. It treats genotype effects as random effects with mean 0 and tests 
the variance component, which greatly reduces the number of parameters in the test, 
compared with multivariate tests. Assuming the individuals are unrelated, SKAT is a 
flexible and computationally efficient approach. Moreover, it calculates the p-value 
analytically without permutation. 
 
1.5   Gene by Environment Interaction 
Gene by environment interaction has become of great interest in genetic association 
studies. Kraft et al. [2007] proposed general approaches for gene by environment 
interaction analysis in the case-control context. Moreover, their approach can also be 
applied for quantitative traits. Without loss of generality, we assume a single marker test 
with a common genetic variant   and only one environmental covariate  . We are 
interested in testing the interaction of   and    on the trait  : 
                          
One strategy is to test a single parameter          versus        , using either Wald, 
likelihood ratio, or score test. This is an interaction-only test. Another approach is to 
perform a joint test on the genetic main effect and gene by environment interaction, 
corresponding to             versus         or     . By performing the 
interaction-only test we are interested in the gene by environment interaction, and by 
performing the joint test we are actually testing if there is any genetic association with the 
marker, allowing for gene by environment interaction. 
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Gene by environment interaction analysis has also been proposed in the meta-analysis 
context [Manning et al., 2011]. Since the effect size of genetic markers are often of great 
interest in genetic association studies, effect size based meta-analysis approaches are 
preferred over p-value based approaches. When we perform an interaction-only test, we 
would use univariate meta-analysis; when we perform a joint test on the genetic main 
effect and gene by environment interaction, we would use bivariate meta-analysis. In 
both cases, the fixed effects model is widely applied, albeit it is not valid in the presence 
of heterogeneity. 
 
1.6   Dissertation Outline 
In this dissertation, we develop novel statistical methods to facilitate research in genetic 
association studies. Our work involves meta-analysis, family samples, rare genetic 
variants analysis, and gene by environment interaction analysis. Each chapter consists of 
methodological development, extensive simulation studies, and a real data application 
example. 
 
In Chapter 2, we develop a method of moments estimator for the between-study 
covariance matrix in random effects model multivariate meta-analysis [Chen, Manning 
and Dupuis, 2012]. The motivation was to solve the heterogeneity issue in the joint meta-
analysis of genetic main effect and gene by environment interaction, in the context of 
bivariate meta-analysis. However, we note that our approach is a general statistical 
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method in multivariate meta-analysis, with application not limited to genetic association 
studies. 
 
In Chapter 3, we combine the approaches for family data analysis and rare genetic 
variants analysis, and develop SKAT for quantitative traits in family samples [Chen, 
Meigs and Dupuis, 2013]. We expect this approach to facilitate rare genetic variants 
analysis in cohorts with family samples, such as the Framingham Heart Study (FHS), or 
individuals with cryptic relatedness. 
 
In Chapter 4, we extend the methodology of SKAT to the context of gene by environment 
interaction analysis. We derive the interaction-only SKAT-type tests for both unrelated 
and related individuals. We hope this work will encourage investigators to study gene by 
environment interaction using rare genetic variants. 
 
In Chapter 5, we summarize the findings and outline future work directions. 
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Chapter 2 A Method of Moments Estimator in Random Effects Multivariate Meta-
Analysis 
 
2.1   Introduction 
Meta-analysis has been widely used to increase precision and power by combining 
studies [Cohn and Becker, 2003]. Assuming that the effect to be estimated is the same in 
all studies, the fixed effect meta-analysis is often successfully used to combine studies 
and obtain a point estimate for the effect size and its standard error. However, the 
underlying assumption of equal effect sizes of the fixed effect model may be violated 
[DerSimonian and Laird, 1986]. Different studies may come from different populations, 
use different protocols and have different levels of confounding or effect modifying 
variables. Thus, the studies may not share a common effect size. In the presence of 
heterogeneity, the fixed effect model underestimates the standard error of the point 
estimate by ignoring the between-study variance. False positive findings may be 
generated when the fixed effect model is inappropriately used. 
 
The random effect model allows both within-study and between-study variances, and is 
more conservative than the fixed effect model in declaring significance of the effect size 
of interest. In the presence of heterogeneity, the random effect model provides more 
appropriate standard error of the point estimate and better confidence interval than the 
fixed effect model. When meta-analyzing a single parameter of interest, one can estimate 
the between-study variance by using the EM algorithm [Dempster, Laird and Rubin, 1977] 
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or other iterative methods; a noniterative method of moments estimator has also been 
proposed by DerSimonian and Laird [1986]. It was derived by equating the homogeneity 
test statistic to its expectation, in the presence of heterogeneity. 
 
Meta-analysis has also been applied to two or more correlated effect estimates 
[Raudenbush, Becker and Kalaian, 1988], such as regression coefficients [Becker and Wu, 
2007]. Analogous to the univariate case in which the inverse variance is used as the 
weight, the inverse of the covariance matrix is the weight in the multivariate fixed effect 
model. Random effect models have also been proposed to incorporate the between-study 
covariance matrix [Berkey et al., 1998; van Houwelingen, Arends and Stijnen, 2002; 
Riley et al., 2007]. However, the iterative procedure is often computer intensive and may 
not reach convergence. Recently, an extended DerSimonian and Laird’s method of 
moments estimator was proposed to solve the between-study covariance matrix [Jackson, 
White and Thompson, 2010]. Though this method is a noniterative approach, it requires 
calculating each element of the matrix separately, and it is not invariant to 
reparametrization of effect sizes. 
 
In this chapter, we propose a novel method of moments estimator for the between-study 
covariance matrix in the multivariate meta-analysis. It is also a multivariate extension of 
DerSimonian and Laird’s univariate method of moments estimator. To our knowledge, 
this is the first noniterative estimator for the between-study covariance matrix in the 
matrix form. It is invariant to linear transformations. We perform a simulation study to 
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compare our method with the restricted maximum likelihood (REML) method [Jennrich 
and Schluchter, 1986] and Jackson’s multivariate DerSimonian and Laird’s method. We 
also apply the three random effect methods and the fixed effect approach to a real data 
example. 
 
2.2   Fixed Effect Multivariate Meta-Analysis 
Suppose we are interested in meta-analyzing   correlated effects from   studies. To 
estimate the true effect sizes 
   
  
  
 
  
    
we need effect estimates and their covariance matrix from individual studies. For study   
(     ), we denote the effect estimates 
    
   
   
 
   
  
and their covariance matrix   . 
 
To meta-analyze vectors   ,   , …,    and get a summary estimate, we need generalized 
least squares (GLS) methods instead of ordinary least squares (OLS) methods, because 
the variances of effect estimates from different studies are unequal. We first stack the   
vectors to get a long vector with length    
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Assuming that the   studies are uncorrelated, we make a blockwise diagonal matrix 
  
 
 
 
 
 
kΣ
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Σ

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

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00
00
2
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This is the covariance matrix of vector  . 
 
We assume the following model holds: 
                        
where  is a stack of   identity matrices of size    , and we assume that the error   
follows a multivariate normal distribution with means 0 and covariance matrix  , which 
is the covariance matrix of vector  . 
 
The fixed effect model summary estimator [Raudenbush, Becker and Kalaian, 1988; 
Becker and Wu, 2007] is 
        
               
with covariance estimator 
             
         
The null hypothesis of homogeneity 
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can be tested using the homogeneity test statistic 
            
             
  is a scalar. Under the null hypothesis of no heterogeneity, it asymptotically follows a 
chi-square distribution with        degrees of freedom [Becker and Wu, 2007]. 
 
2.3   Random Effect Multivariate Meta-Analysis 
Similarly to the fixed effect model, we assume 
                              
We assume that the error   follows a multivariate normal distribution with means 0 and 
covariance matrix  . The random effect vector 
   
  
  
 
  
   
where    (     ) follows a multivariate normal distribution with mean 0 and 
covariance matrix  . Thus the covariance matrix of vector   is 
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
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   (     ) is the within-study   covariance matrix defined above,      is the     
identity matrix,   is the between-study covariance matrix. The symbol  denotes the 
Kronecker product of two matrices. 
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The random effect model summary estimator is 
        
               
with covariance estimator 
             
         
The crucial step for the random effect approach is to estimate the between-study 
covariance matrix  . In this chapter we use the following three methods. 
 
2.3.1 Restricted Maximum Likelihood Method 
The REML estimation can be performed by maximizing 
      
 
 
       
 
 
           
 
 
 
                                               
under the constraint that   is positive semi-definite [Jackson, White and Thompson, 2010; 
Jennrich and Schluchter, 1986]. 
 
Suppose   can be written as 
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The algorithm can be implemented as maximizing over          parameters   
      
              under constraints   
            . 
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2.3.2 Jackson’s Multivariate DerSimonian and Laird’s Method 
Jackson’s multivariate DerSimonian and Laird’s method estimates each entry of   
separately [Jackson, White and Thompson, 2010]. 
      
 
                            
               
 
     
       
               
 
    
 
       
              
 
   
 
 
               
 
   
 
 
               
 
    
 
 
              
 
   
 
 
               
 
   
 
is the element on row   (     ) and column   (     ) of   , where 
       
 
     
               
 
   
 
 
               
 
   
   
and       is the  th (     ) element in the vector    (     ),         is the 
element on row   (     ) and column   (     ) of    (     ). While the 
calculation is generally faster than REML, Jackson’s method requires calculating    
weighted means        as intermediates for a     matrix   , and it is not invariant to 
reparametrization of effect sizes. 
 
2.3.3 Chen’s Multivariate DerSimonian and Laird’s Method 
Let 
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where   ,    (     ) are defined above,     is the fixed effect estimate defined above. 
Then 
          
A symmetric method of moments estimator for   is 
   
         
 
   
See Appendix A for the derivation. 
 
2.3.3.1 Invariance Property to Linear Transformations 
Our estimator is invariant to linear transformations. Suppose the effect sizes are 
transformed 
          
where   is an invertible     matrix, then 
             
           
   
for      , where   is the number of studies. We have 
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Thus, the meta-analysis of linearly transformed effects gives the same results. 
 
2.3.3.2 Connection with Univariate DerSimonian and Laird’s Estimator 
Our estimator is a multivariate extension of DerSimonian and Laird’s method of 
moments estimator for the between-study variance. When the number of effects    , 
     
  (variance of the effect size estimate in study  ),      (between-study variance) 
are all scalar. Thus the homogeneity test statistic can be written as 
   
 
  
      
 
  
 
 
   
   
It follows that 
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The method of moments estimator 
    
       
 
 
       
 
  
 
  
 
 
    
 
 
  
 
 
   
 
 
  
 
 
   
 
 
 
is the same as DerSimonian and Laird’s method of moments estimator. 
 
2.3.3.3 Homogeneity Test in the Presence of Heterogeneity 
In the presence of heterogeneity, the homogeneity test statistic   no longer follows a chi-
square distribution. When the between-study covariance matrix    , the homogeneity 
test statistic 
            
           
          
 
  
          
 
   
   
Its expectation can be written as 
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Under the hypothesis of no heterogeneity,    ,            . This result is 
consistent with the expectation of a chi-square distribution with        degrees of 
freedom, which corresponds to the asymptotic distribution of   in the absence of 
heterogeneity. It is obvious that in all circumstances the homogeneity test statistic 
               
 
2.3.4 Positive Semi-Definiteness of Covariance Matrix Estimators 
Since   is a covariance matrix, it should be positive semi-definite. While we can do the 
maximization under the constraint that   is positive semi-definite using the REML 
method, we generally have no guarantee that Jackson’s or Chen’s method of moments 
estimator would be positive semi-definite, especially when heterogeneity is low. This is 
analogous to the one dimensional case, whereas     may be negative if        , 
when heterogeneity is low. One may leave a negative     as is, or set it to 0 because the 
variance cannot be negative. Similarly, we have two strategies for a between-study 
covariance matrix estimate which is not positive semi-definite: leave it as is, or make it a 
positive semi-definite matrix. A remedy for a covariance matrix estimate which is not 
positive semi-definite is discussed below, which we adopted in all the simulation studies 
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and real data analysis. Jackson, White and Thompson [2010] used the same strategy in 
their paper. 
 
Since    is symmetric, it is diagonalizable. There exists an orthogonal matrix   such that 
          
where  is a diagonal matrix with all eigenvalues of    on the diagonal, then 
         
Let     be a diagonal matrix with the same elements as , except that all negative 
elements on the diagonal in   are set to be 0 in    . Then               is positive 
semi-definite. However,       is a biased estimator. 
 
2.4   Simulation Studies 
2.4.1 Simulation Design 
To compare the performance of the REML method, multivariate DerSimonian and 
Laird’s method by Jackson et al. (MDLJ) and multivariate DerSimonian and Laird’s 
method by Chen et al. (MDLC), we conducted simulation studies in the context of 
bivariate meta-analysis. 
 
We considered 10 studies with different sample sizes. One hundred between-study 
variances were generated from a chi-square distribution with 1 df, and values less than 
0.016 or greater than 2.7 were discarded (corresponding approximately to the 10% and 90% 
quantiles of 1 df chi-square distribution). Then we randomly chose 2 sets of 10 variances 
25 
 
 
out of the remaining values, sorted and paired them. The smallest pair was assigned to the 
first study as the within-study variances of the two effects and so on until the largest pair 
was assigned to the last study. The within-study correlation was set to 0.2 or 0.8 for all 10 
studies. 
 
We followed the procedure by Higgins and Thompson to calculate the between-study 
variances [Jackson, White and Thompson, 2010; Higgins and Thompson, 2002]. Since 
the variances for both outcomes were simulated from the same population, we first 
calculated the typical within-study variance 
  
     
   
       
  
  
 
   
   
  
  
 
    
 
   
  
  
 
   
   
where   
  was generated as discussed above. For this parameter setting we have   
  
    . Then we computed the between-study variances from 
  
  
   
       
 
   
        
 
  
  
   
       
 
   
        
 
where   
  and   
  are the proportions of marginal variation in the first and second effects 
due to heterogeneity, respectively.     and     are the between-study variances for the 
first and second effects. We considered 9 scenarios, in which each of   
  and   
  was set to 
0.2, 0.5 or 0.8 to simulate low, moderate and high heterogeneity for each effect. The 
between-study correlation was set to 0.2 or 0.8 to calculate the covariance. 
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For each study   (      ), we generated the effect size vector    from a bivariate 
normal distribution with mean 0 and covariance matrix     , where    is the within-
study covariance matrix and   is the between-study covariance matrix. 
 
2.4.2 Simulation Results 
We summarized the simulation results from 1000 replicates for 10 studies with between-
study correlation 0.2 and within-study correlation 0.2 in Table 2.1 and Table 2.2. We 
only presented results for the first effect and the covariance, since the second effect 
shows similar results. Table 2.1 shows the bias, mean squared error (MSE) for the first 
summary effect estimator     and 95% confidence interval coverage for the first effect 
size. The confidence interval was constructed as                     [Follmann and 
Proschan, 1999]. Table 2.2 shows the bias of the between-study variance estimator for the 
first effect      and that of the between-study covariance estimator     , and their 
corresponding mean squared errors. It also shows the proportion of the between-study 
covariance matrix estimate lying on the boundary of its parameter space: either at least 
one of the variance estimates is 0, or the absolute value of the correlation coefficient is 1. 
Since the between-study covariance matrix is always positive semi-definite, this column 
also indicates the percentage of the between-study covariance matrix not being positive 
definite, that is, its minimum eigenvalue is equal to 0. To allow for rounding errors, we 
consider values less than 10
-8
 to be equal to 0. 
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Table 2.1   Simulation results for summary effect estimates (between-study correlation 
0.2, within-study correlation 0.2) 
  
    
              Method Bias     MSE     Coverage     
0.2 0.2 0.0375 0.0075 0.0375 REML –0.0065 0.0331 0.962 
     MDLJ –0.0073 0.0326 0.963 
     MDLC –0.0072 0.0326 0.963 
0.2 0.5 0.0375 0.0150 0.1500 REML –0.0001 0.0311 0.952 
     MDLJ –0.0017 0.0307 0.957 
     MDLC –0.0016 0.0307 0.958 
0.2 0.8 0.0375 0.0300 0.6000 REML 0.0048 0.0334 0.962 
     MDLJ 0.0054 0.0328 0.969 
     MDLC 0.0058 0.0328 0.967 
0.5 0.2 0.1500 0.0150 0.0375 REML 0.0103 0.0562 0.934 
     MDLJ 0.0104 0.0548 0.938 
     MDLC 0.0102 0.0549 0.939 
0.5 0.5 0.1500 0.0300 0.1500 REML 0.0108 0.0527 0.924 
     MDLJ 0.0121 0.0521 0.930 
     MDLC 0.0120 0.0521 0.929 
0.5 0.8 0.1500 0.0600 0.6000 REML –0.0001 0.0499 0.925 
     MDLJ –0.0012 0.0492 0.937 
     MDLC –0.0009 0.0492 0.935 
0.8 0.2 0.6000 0.0300 0.0375 REML 0.0099 0.1132 0.929 
     MDLJ 0.0112 0.1130 0.933 
     MDLC 0.0113 0.1131 0.933 
0.8 0.5 0.6000 0.0600 0.1500 REML 0.0055 0.1147 0.925 
     MDLJ 0.0046 0.1136 0.934 
     MDLC 0.0045 0.1136 0.932 
0.8 0.8 0.6000 0.1200 0.6000 REML 0.0256 0.1003 0.925 
     MDLJ 0.0264 0.0998 0.928 
     MDLC 0.0262 0.0998 0.930 
  
  and   
  denote the proportions of marginal variation in the first and second effects due 
to heterogeneity.     and     denote the between-study variances for the first and second 
effects, and     denotes the between-study covariance. Coverage denotes the coverage of 
95% confidence interval. 
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Table 2.2   Simulation results for between-study covariance matrix (between-study 
correlation 0.2, within-study correlation 0.2) 
  
    
  Method Bias      Bias      MSE      MSE      % boundary 
0.2 0.2 REML 0.0491 0.0167 0.0235 0.0078 0.888 
  MDLJ 0.0473 0.0086 0.0142 0.0051 0.819 
  MDLC 0.0476 0.0085 0.0142 0.0052 0.824 
0.2 0.5 REML 0.0452 0.0096 0.0218 0.0118 0.838 
  MDLJ 0.0447 0.0011 0.0154 0.0092 0.748 
  MDLC 0.0447 0.0009 0.0152 0.0094 0.751 
0.2 0.8 REML 0.0553 0.0082 0.0270 0.0343 0.708 
  MDLJ 0.0499 –0.0044 0.0164 0.0262 0.629 
  MDLC 0.0505 –0.0044 0.0168 0.0262 0.641 
0.5 0.2 REML 0.0369 0.0185 0.0470 0.0137 0.814 
  MDLJ 0.0265 0.0091 0.0361 0.0104 0.738 
  MDLC 0.0267 0.0089 0.0361 0.0105 0.737 
0.5 0.5 REML 0.0278 0.0051 0.0490 0.0195 0.731 
  MDLJ 0.0207 –0.0017 0.0317 0.0161 0.621 
  MDLC 0.0213 –0.0018 0.0315 0.0162 0.622 
0.5 0.8 REML 0.0350 0.0034 0.0530 0.0500 0.552 
  MDLJ 0.0265 –0.0079 0.0383 0.0454 0.454 
  MDLC 0.0268 –0.0071 0.0380 0.0458 0.451 
0.8 0.2 REML 0.0296 0.0125 0.2405 0.0347 0.739 
  MDLJ 0.0296 –0.0009 0.2763 0.0280 0.619 
  MDLC 0.0299 –0.0006 0.2764 0.0279 0.612 
0.8 0.5 REML 0.0769 0.0149 0.3099 0.0567 0.545 
  MDLJ 0.0504 0.0007 0.2876 0.0501 0.443 
  MDLC 0.0507 0.0013 0.2879 0.0500 0.439 
0.8 0.8 REML 0.0065 0.0034 0.2153 0.1108 0.288 
  MDLJ 0.0033 0.0048 0.2551 0.1358 0.210 
  MDLC 0.0042 0.0055 0.2559 0.1350 0.214 
  
  and   
  denote the proportions of marginal variation in the first and second effects due 
to heterogeneity. % boundary denotes the proportion of the between-study covariance 
matrix estimate lying on the boundary of its parameter space. 
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We can see from Tables 2.1 and 2.2 that all three methods give very similar results, and 
our new approach is closer to Jackson’s method than to REML. This is not surprising 
because REML is a likelihood-based iterative method, while the other two are methods of 
moments. In all scenarios REML gives more between-study covariance matrix estimates 
at the boundary than the other non-iterative methods. 
 
Bias of      is generally greater than 0, because we pull back negative eigenvalues to 0 
when fixing covariance matrix estimates that are not positive semi-definite, we somehow 
bias the diagonal elements upwards. We can see that as the heterogeneity increases, this 
bias generally decreases, and the proportion of between-study covariance matrix 
estimates at the boundary also decreases. This is consistent with our prior knowledge that 
fixed effect models are usually preferred when heterogeneity is low and random effect 
models are more appropriate when heterogeneity is high. 
 
Simulation results from 1000 replicates for 10 studies with other correlation coefficient 
settings are summarized in Tables 2.3 – 2.8. 
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Table 2.3   Simulation results for summary effect estimates (between-study correlation 
0.2, within-study correlation 0.8) 
  
    
              Method Bias     MSE     Coverage     
0.2 0.2 0.0375 0.0075 0.0375 REML –0.0065 0.0331 0.962 
     MDLJ –0.0073 0.0326 0.963 
     MDLC –0.0072 0.0326 0.963 
0.2 0.5 0.0375 0.0150 0.1500 REML –0.0001 0.0311 0.952 
     MDLJ –0.0017 0.0307 0.957 
     MDLC –0.0016 0.0307 0.958 
0.2 0.8 0.0375 0.0300 0.6000 REML 0.0048 0.0334 0.962 
     MDLJ 0.0054 0.0328 0.969 
     MDLC 0.0058 0.0328 0.967 
0.5 0.2 0.1500 0.0150 0.0375 REML 0.0103 0.0562 0.934 
     MDLJ 0.0104 0.0548 0.938 
     MDLC 0.0102 0.0549 0.939 
0.5 0.5 0.1500 0.0300 0.1500 REML 0.0108 0.0527 0.924 
     MDLJ 0.0121 0.0521 0.930 
     MDLC 0.0120 0.0521 0.929 
0.5 0.8 0.1500 0.0600 0.6000 REML –0.0001 0.0499 0.925 
     MDLJ –0.0012 0.0492 0.937 
     MDLC –0.0009 0.0492 0.935 
0.8 0.2 0.6000 0.0300 0.0375 REML 0.0099 0.1132 0.929 
     MDLJ 0.0112 0.1130 0.933 
     MDLC 0.0113 0.1131 0.933 
0.8 0.5 0.6000 0.0600 0.1500 REML 0.0055 0.1147 0.925 
     MDLJ 0.0046 0.1136 0.934 
     MDLC 0.0045 0.1136 0.932 
0.8 0.8 0.6000 0.1200 0.6000 REML 0.0256 0.1003 0.925 
     MDLJ 0.0264 0.0998 0.928 
     MDLC 0.0262 0.0998 0.930 
  
  and   
  denote the proportions of marginal variation in the first and second effects due 
to heterogeneity.     and     denote the between-study variances for the first and second 
effects, and     denotes the between-study covariance. Coverage denotes the coverage of 
95% confidence interval. 
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Table 2.4   Simulation results for between-study covariance matrix (between-study 
correlation 0.2, within-study correlation 0.8) 
  
    
  Method Bias      Bias      MSE      MSE      % boundary 
0.2 0.2 REML 0.0473 0.0396 0.0159 0.0106 0.819 
  MDLJ 0.0426 0.0281 0.0134 0.0090 0.752 
  MDLC 0.0418 0.0261 0.0125 0.0081 0.752 
0.2 0.5 REML 0.0467 0.0363 0.0192 0.0149 0.765 
  MDLJ 0.0431 0.0188 0.0136 0.0130 0.659 
  MDLC 0.0438 0.0201 0.0141 0.0133 0.658 
0.2 0.8 REML 0.0516 0.0584 0.0219 0.0388 0.670 
  MDLJ 0.0541 0.0148 0.0149 0.0333 0.549 
  MDLC 0.0635 0.0256 0.0196 0.0438 0.562 
0.5 0.2 REML 0.0532 0.0502 0.0536 0.0224 0.740 
  MDLJ 0.0330 0.0280 0.0412 0.0156 0.663 
  MDLC 0.0308 0.0272 0.0388 0.0152 0.652 
0.5 0.5 REML 0.0442 0.0387 0.0498 0.0265 0.623 
  MDLJ 0.0376 0.0202 0.0414 0.0228 0.518 
  MDLC 0.0386 0.0221 0.0412 0.0222 0.517 
0.5 0.8 REML 0.0384 0.0403 0.0557 0.0540 0.506 
  MDLJ 0.0272 0.0088 0.0346 0.0495 0.389 
  MDLC 0.0347 0.0109 0.0410 0.0563 0.409 
0.8 0.2 REML 0.0601 0.0493 0.2386 0.0364 0.728 
  MDLJ 0.0140 0.0040 0.2838 0.0298 0.576 
  MDLC 0.0198 0.0086 0.3190 0.0322 0.598 
0.8 0.5 REML 0.0215 0.0388 0.2269 0.0551 0.492 
  MDLJ –0.0110 0.0094 0.2642 0.0503 0.400 
  MDLC –0.0117 0.0098 0.2764 0.0534 0.393 
0.8 0.8 REML 0.0118 0.0138 0.2125 0.1221 0.280 
  MDLJ –0.0106 –0.0176 0.2189 0.1241 0.203 
  MDLC –0.0033 –0.0101 0.2391 0.1295 0.247 
  
  and   
  denote the proportions of marginal variation in the first and second effects due 
to heterogeneity. % boundary denotes the proportion of the between-study covariance 
matrix estimate lying on the boundary of its parameter space. 
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Table 2.5   Simulation results for summary effect estimates (between-study correlation 
0.8, within-study correlation 0.2) 
  
    
              Method Bias     MSE     Coverage     
0.2 0.2 0.0375 0.0300 0.0375 REML –0.0000 0.0308 0.958 
     MDLJ 0.0009 0.0310 0.959 
     MDLC 0.0008 0.0310 0.958 
0.2 0.5 0.0375 0.0600 0.1500 REML –0.0066 0.0325 0.956 
     MDLJ –0.0053 0.0327 0.956 
     MDLC –0.0052 0.0326 0.957 
0.2 0.8 0.0375 0.1200 0.6000 REML 0.0065 0.0319 0.960 
     MDLJ 0.0067 0.0317 0.967 
     MDLC 0.0065 0.0317 0.967 
0.5 0.2 0.1500 0.0600 0.0375 REML –0.0082 0.0495 0.934 
     MDLJ –0.0099 0.0493 0.951 
     MDLC –0.0099 0.0492 0.952 
0.5 0.5 0.1500 0.1200 0.1500 REML –0.0049 0.0484 0.950 
     MDLJ –0.0044 0.0484 0.951 
     MDLC –0.0046 0.0485 0.953 
0.5 0.8 0.1500 0.2400 0.6000 REML –0.0075 0.0494 0.941 
     MDLJ –0.0075 0.0496 0.943 
     MDLC –0.0074 0.0495 0.945 
0.8 0.2 0.6000 0.1200 0.0375 REML –0.0024 0.1075 0.932 
     MDLJ –0.0003 0.1081 0.930 
     MDLC –0.0001 0.1083 0.931 
0.8 0.5 0.6000 0.2400 0.1500 REML –0.0070 0.1008 0.926 
     MDLJ –0.0073 0.1006 0.925 
     MDLC –0.0074 0.1005 0.926 
0.8 0.8 0.6000 0.4800 0.6000 REML –0.0121 0.1094 0.936 
     MDLJ –0.0136 0.1087 0.943 
     MDLC –0.0134 0.1087 0.941 
  
  and   
  denote the proportions of marginal variation in the first and second effects due 
to heterogeneity.     and     denote the between-study variances for the first and second 
effects, and     denotes the between-study covariance. Coverage denotes the coverage of 
95% confidence interval. 
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Table 2.6   Simulation results for between-study covariance matrix (between-study 
correlation 0.8, within-study correlation 0.2) 
  
    
  Method Bias      Bias      MSE      MSE      % boundary 
0.2 0.2 REML 0.0523 0.0064 0.0343 0.0103 0.915 
  MDLJ 0.0497 –0.0015 0.0173 0.0062 0.859 
  MDLC 0.0499 –0.0016 0.0173 0.0062 0.860 
0.2 0.5 REML 0.0509 0.0041 0.0208 0.0134 0.845 
  MDLJ 0.0507 –0.0057 0.0157 0.0114 0.768 
  MDLC 0.0512 –0.0060 0.0158 0.0116 0.781 
0.2 0.8 REML 0.0532 0.0074 0.0228 0.0374 0.779 
  MDLJ 0.0510 –0.0054 0.0152 0.0300 0.694 
  MDLC 0.0515 –0.0056 0.0152 0.0305 0.698 
0.5 0.2 REML 0.0333 0.0000 0.0511 0.0132 0.866 
  MDLJ 0.0306 –0.0090 0.0406 0.0114 0.792 
  MDLC 0.0307 –0.0089 0.0405 0.0116 0.790 
0.5 0.5 REML 0.0364 –0.0059 0.0419 0.0227 0.771 
  MDLJ 0.0301 –0.0167 0.0328 0.0192 0.682 
  MDLC 0.0305 –0.0167 0.0328 0.0194 0.675 
0.5 0.8 REML 0.0422 –0.0034 0.0457 0.0628 0.677 
  MDLJ 0.0343 –0.0139 0.0356 0.0560 0.624 
  MDLC 0.0344 –0.0134 0.0351 0.0561 0.631 
0.8 0.2 REML 0.0145 –0.0011 0.2381 0.0330 0.802 
  MDLJ 0.0132 –0.0077 0.2815 0.0328 0.691 
  MDLC 0.0130 –0.0077 0.2813 0.0328 0.694 
0.8 0.5 REML –0.0048 –0.0263 0.2141 0.0558 0.691 
  MDLJ –0.0000 –0.0273 0.2529 0.0649 0.597 
  MDLC –0.0004 –0.0275 0.2509 0.0642 0.598 
0.8 0.8 REML 0.0283 –0.0067 0.2290 0.1503 0.511 
  MDLJ 0.0227 –0.0103 0.2466 0.1845 0.437 
  MDLC 0.0225 –0.0111 0.2459 0.1834 0.425 
  
  and   
  denote the proportions of marginal variation in the first and second effects due 
to heterogeneity. % boundary denotes the proportion of the between-study covariance 
matrix estimate lying on the boundary of its parameter space. 
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Table 2.7   Simulation results for summary effect estimates (between-study correlation 
0.8, within-study correlation 0.8) 
  
    
              Method Bias     MSE     Coverage     
0.2 0.2 0.0375 0.0300 0.0375 REML 0.0066 0.0317 0.952 
     MDLJ 0.0062 0.0307 0.949 
     MDLC 0.0057 0.0306 0.952 
0.2 0.5 0.0375 0.0600 0.1500 REML 0.0095 0.0322 0.952 
     MDLJ 0.0077 0.0325 0.954 
     MDLC 0.0085 0.0327 0.948 
0.2 0.8 0.0375 0.1200 0.6000 REML –0.0054 0.0303 0.966 
     MDLJ –0.0081 0.0309 0.955 
     MDLC –0.0081 0.0315 0.958 
0.5 0.2 0.1500 0.0600 0.0375 REML –0.0129 0.0428 0.946 
     MDLJ –0.0126 0.0417 0.946 
     MDLC –0.0119 0.0420 0.946 
0.5 0.5 0.1500 0.1200 0.1500 REML 0.0037 0.0483 0.936 
     MDLJ 0.0049 0.0477 0.931 
     MDLC 0.0037 0.0479 0.938 
0.5 0.8 0.1500 0.2400 0.6000 REML –0.0047 0.0502 0.930 
     MDLJ –0.0051 0.0506 0.927 
     MDLC –0.0037 0.0518 0.917 
0.8 0.2 0.6000 0.1200 0.0375 REML –0.0258 0.1043 0.931 
     MDLJ –0.0257 0.1050 0.927 
     MDLC –0.0269 0.1053 0.920 
0.8 0.5 0.6000 0.2400 0.1500 REML –0.0031 0.1126 0.925 
     MDLJ –0.0041 0.1131 0.918 
     MDLC –0.0045 0.1128 0.920 
0.8 0.8 0.6000 0.4800 0.6000 REML 0.0008 0.1025 0.926 
     MDLJ 0.0004 0.1041 0.923 
     MDLC –0.0003 0.1038 0.922 
  
  and   
  denote the proportions of marginal variation in the first and second effects due 
to heterogeneity.     and     denote the between-study variances for the first and second 
effects, and     denotes the between-study covariance. Coverage denotes the coverage of 
95% confidence interval. 
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Table 2.8   Simulation results for between-study covariance matrix (between-study 
correlation 0.8, within-study correlation 0.8) 
  
    
  Method Bias      Bias      MSE      MSE      % boundary 
0.2 0.2 REML 0.0488 0.0355 0.0219 0.0137 0.899 
  MDLJ 0.0427 0.0248 0.0147 0.0102 0.840 
  MDLC 0.0409 0.0217 0.0136 0.0093 0.851 
0.2 0.5 REML 0.0406 0.0230 0.0156 0.0150 0.825 
  MDLJ 0.0349 0.0057 0.0111 0.0132 0.743 
  MDLC 0.0355 0.0071 0.0114 0.0137 0.750 
0.2 0.8 REML 0.0533 0.0409 0.0217 0.0428 0.748 
  MDLJ 0.0449 0.0006 0.0151 0.0349 0.639 
  MDLC 0.0483 0.0001 0.0157 0.0399 0.626 
0.5 0.2 REML 0.0330 0.0365 0.0431 0.0215 0.811 
  MDLJ 0.0198 0.0160 0.0300 0.0137 0.731 
  MDLC 0.0174 0.0150 0.0302 0.0139 0.734 
0.5 0.5 REML 0.0296 0.0226 0.0379 0.0267 0.723 
  MDLJ 0.0205 0.0062 0.0327 0.0255 0.644 
  MDLC 0.0189 0.0071 0.0321 0.0246 0.627 
0.5 0.8 REML 0.0445 0.0209 0.0572 0.0692 0.575 
  MDLJ 0.0329 –0.0000 0.0434 0.0725 0.507 
  MDLC 0.0349 0.0011 0.0510 0.0839 0.500 
0.8 0.2 REML 0.0467 0.0506 0.2187 0.0499 0.732 
  MDLJ 0.0334 0.0175 0.2852 0.0420 0.631 
  MDLC 0.0439 0.0294 0.3144 0.0531 0.645 
0.8 0.5 REML 0.0187 0.0226 0.2210 0.0731 0.592 
  MDLJ 0.0164 0.0038 0.2807 0.0769 0.491 
  MDLC 0.0194 0.0067 0.2913 0.0827 0.486 
0.8 0.8 REML 0.0222 0.0225 0.2453 0.2030 0.306 
  MDLJ 0.0194 0.0099 0.2795 0.2294 0.261 
  MDLC 0.0126 0.0054 0.2773 0.2288 0.237 
  
  and   
  denote the proportions of marginal variation in the first and second effects due 
to heterogeneity. % boundary denotes the proportion of the between-study covariance 
matrix estimate lying on the boundary of its parameter space. 
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2.4.3 Additional Simulation Studies 
We performed 6 additional simulation studies to investigate the effect of the number of 
studies on the results. We set   
  and   
  to be 0.5, between-study and within-study 
correlation coefficients to be 0.2, and let the number of studies change from 10 to 5, 20, 
50, 100, 200 and 500. In each scenario, we analyzed 1000 replicates. Since all three 
methods give similar results, only results using our new method are shown in Figure 2.1 
and Table 2.9. As the number of studies increases, mean squared errors of    , the 
summary effect estimate for the first effect, and     , the between-study variance estimate 
for the first effect, decrease. This is reasonable because the large-sample properties of 
estimators in a meta-analysis depend on the number of studies. As the number of studies 
goes to infinity, mean squared errors converge to 0. 
 
We can also see that as the number of studies increases, the proportion of the between-
study covariance matrix estimate lying on the boundary of its parameter space (matrix 
with minimum eigenvalue 0) decreases dramatically, even though the heterogeneity is 
only moderate. As we fix fewer and fewer covariance matrices that are not positive semi-
definite, bias of      also decreases quickly to near 0. There is no clear relationship 
between the coverage of 95% confidence interval for    and the number of studies, 
although only the largest sample of 500 studies has the correct coverage. 
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Figure 2.1   Simulation results from various numbers of studies (proportions of marginal 
variation due to heterogeneity 0.5, between-study correlation 0.2, within-study 
correlation 0.2) 
 
(A) Mean squared errors of    , the first summary effect estimate, and     , the between-
study variance estimate for the first effect, and proportion of the between-study 
covariance matrix estimate lying on the boundary of its parameter space. (B) Coverage of 
95% confidence interval for   , the first effect size. 
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Table 2.9   Simulation results from various numbers of studies (proportions of marginal 
variation due to heterogeneity 0.5, between-study correlation 0.2, within-study 
correlation 0.2) 
k Bias     
MSE 
    
Cover-
age     
Bias      Bias      
MSE 
     
MSE 
     
% 
boundary 
5 –0.0064 0.1135 0.970 0.0989 0.0023 0.1366 0.0513 0.831 
10 0.0120 0.0521 0.929 0.0213 –0.0018 0.0315 0.0162 0.622 
20 0.0031 0.0241 0.932 0.0004 0.0022 0.0149 0.0082 0.329 
50 0.0001 0.0089 0.939 –0.0006 0.0002 0.0062 0.0030 0.055 
100 –0.0022 0.0048 0.929 0.0012 0.0003 0.0032 0.0016 0.003 
200 0.0004 0.0021 0.963 0.0002 0.0003 0.0015 0.0008 0.000 
500 0.0005 0.0009 0.951 –0.0001 –0.0009 0.0006 0.0003 0.000 
k denotes the number of studies in the meta-analysis. Coverage denotes the coverage of 
95% confidence interval. % boundary denotes the proportion of the between-study 
covariance matrix estimate lying on the boundary of its parameter space. 
 
2.5   Application 
In this application we use publicly available data from the base year of the High School 
Longitudinal Study of 2009 (HSLS:09) [Ingels et al., 2011] to illustrate our new method 
as a general multivariate meta-analysis approach. HSLS:09 is a nationally representative, 
longitudinal study of more than 21,000 9th graders in 944 schools who will be followed 
through their secondary and postsecondary years. We are interested in testing whether 
sex, socio-economic status and sex by socio-economic status interaction are predictive of 
the mathematics standardized theta score. We estimate the regression coefficients in each 
of the 8 race groups and perform multivariate meta-analyses on the regression 
coefficients to obtain the summary effect estimates. 
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Within each race group  , our model is 
                                        
where     is the mathematics standardized theta score,      is the sex, coded as 1 for 
males and 0 for females,      is the socio-economic status score for student  .      is the 
normally distributed error. The regression results are summarized in Table 2.10. 
 
We use both the fixed effects meta-analysis (FEMA) and random effects models to meta-
analyze the regression coefficients from the 8 race groups. Table 2.11 shows the meta-
analysis results. For this data, the homogeneity test statistic   is 54.6, which 
asymptotically follows a chi-square distribution with 21 degrees of freedom under the 
null hypothesis of no heterogeneity. The p-value of the homogeneity test is 8.1×10
-5
. 
Thus, the assumption of homogeneous effect sizes for the fixed effect model is violated. 
Since the fixed effect model does not take between-study variance into consideration, it 
greatly underestimates the covariance matrix for the summary effect estimates, resulting 
in an inflated Wald test statistic for testing the hypotheses H0:            versus 
H1: at least one of   ,   ,    is not 0, where   ,   ,    are the summary effect sizes for 
sex, socio-economic status score and sex by socio-economic status score interaction, 
respectively. 
 
Jackson’s multivariate DerSimonian and Laird’s method of moments and our method 
give close results, while the restricted maximum likelihood method yields a different 
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between-study covariance matrix estimate. However, all three random effect methods 
give very close summary effect size estimates, and the Wald test statistic reduces 
dramatically, compared to that from the fixed effect model. 
 
 
Table 2.10   Regression results from 8 race groups 
Race                         
1 163 0.3161 7.4015 0.4278 2.3568 –1.2105 
9.7029 
0.8524 
–6.1753 
4.4114 
2 1672 –0.3201 6.9426 –0.9816 0.2529 0.1498 
0.7016 
–0.1019 
–0.4167 
0.2743 
3 2218 0.6983 4.6680 –0.2415 0.1444 –0.0652 
0.6481 
0.0433 
–0.3899 
0.2608 
4 204 3.2736 4.3080 0.2052 3.8428 –4.5587 
10.3517 
3.2892 
–6.6684 
4.8268 
5 3311 –0.1599 5.6398 –0.6782 0.1161 –0.0992 
0.4363 
0.0645 
–0.2610 
0.1733 
6 1912 –0.6989 6.3158 –0.7918 0.1603 0.0242 
0.7697 
–0.0129 
–0.4686 
0.3180 
7 110 –3.6094 9.3429 –2.8711 3.2054 –1.1984 
17.8889 
0.8437 
–10.7697 
7.2101 
8 11854 0.2172 6.4078 –0.6093 0.0278 0.0136 
0.1184 
–0.0091 
–0.0716 
0.0482 
   is the sample size in race group  .     is the regression coefficient for sex,     is the 
regression coefficient for socio-economic status score,     is the regression coefficient for 
sex by socio-economic status score interaction in race group  . 
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Table 2.11   Meta-analysis results for 8 race groups 
Method 
    
(SE) 
    
(SE) 
    
(SE)    
Wald 
statistic 
FEMA 0.0788 
(0.1208) 
6.2031 
(0.2448) 
–0.6590 
(0.1550) 
0 0 
0 
0 
0 
0 
4141 
REML –0.0244 
(0.2427) 
6.1674 
(0.4843) 
–0.6679 
(0.1865) 
0.2090 –0.2946 
1.0028 
0.1172 
–0.2567 
0.0657 
431 
MDLJ –0.0612 
(0.2599) 
6.1873 
(0.2973) 
–0.7038 
(0.1888) 
0.2558 –0.1221 
0.1279 
0.0097 
0.0542 
0.0501 
567 
MDLC –0.0604 
(0.2684) 
6.1821 
(0.2887) 
–0.7009 
(0.1894) 
0.2805 –0.0948 
0.1024 
0.0030 
0.0602 
0.0532 
571 
   ,     and     denote the summary effect size estimates for sex, socio-economic status 
score and sex by socio-economic status score interaction, respectively.     ,     ,     ,     , 
    ,      are corresponding elements of the matrix   , the between-study covariance 
matrix estimate. Wald statistic is for testing the hypotheses H0:            versus 
H1: at least one of   ,   ,    is not 0. 
 
2.6   Discussion 
We propose a new method of moments estimator for the between-study covariance 
matrix in the random effect multivariate meta-analysis. We have shown in our simulation 
studies that our method gives similar results to existing random effect model multivariate 
meta-analysis methods. Furthermore, our method and Jackson’s multivariate 
DerSimonian and Laird’s method give very close results in both simulation studies and 
real data analysis. 
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Our estimator is the first matrix form method of moments estimator for the between-
study covariance matrix in the random effect model multivariate meta-analysis. It is 
invariant to linear transformations. As a non-iterative estimator, it is very easy to 
calculate. 
 
Despite its long history in combining published analysis results, meta-analysis is also 
very useful in multi-center or multi-ethnic studies, when different cohorts can share 
results from the same analysis but it is often not feasible to share original data. Generally, 
the fixed effect model is the first choice in a meta-analysis as it is easier to calculate and 
interpret, and it is more powerful than random effect models. However, in the presence of 
heterogeneity, results from the fixed effect model are not valid, and random effect models 
are preferred. When performing the random effect meta-analysis for   effects, Jackson’s 
method requires calculating    weighted means        (     ,      ) in 
intermediate steps, which are not related to corresponding fixed effect summary estimates. 
Specifically, the weighted means        (     ) are the fixed effect summary estimates 
in univariate meta-analyses, instead of the multivariate meta-analysis we desire. In 
contrast, our method directly uses the fixed effect summary estimates vector to calculate 
the between-study covariance matrix estimate. It does not require performing    
additional univariate meta-analyses to calculate the intermediates. We hope our 
computationally easy estimator with nice mathematical properties will help boost 
multivariate meta-analysis using the random effects model. 
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Chapter 3 Sequence Kernel Association Test for Quantitative Traits in Family 
Samples 
 
3.1   Introduction 
In recent years, with the advances in whole-genome sequencing technology, assessing the 
association of rare genetic variants with complex diseases and quantitative traits has 
become of great interest. Rare genetic variants may account for some of the unexplained 
heritability unexplained by genetic loci identified by genome-wide association studies 
(GWAS) [Eichler et al., 2010], because single variant tests used in GWAS are 
underpowered for rare genetic variants [Li and Leal, 2008]. To increase power, burden 
tests have been proposed [Li and Leal, 2008; Morgenthaler and Thilly, 2007; Madsen and 
Browning, 2009; Morris and Zeggini, 2010]; these tests are based on collapsing rare 
genetic variants in a predefined genomic region with either a rare variant indicator or a 
weighted score. These methods are most powerful when all rare genetic variants in the 
region have the same direction of effect and even the same effect size. Alternatively, the 
data-adaptive sum test [Han and Pan, 2010] and step-up approach [Hoffmann, Marini and 
Witte, 2010] do not make any implicit assumptions about the directions of effects and use 
the signs from single marker tests to determine them, but both of these approaches 
require permutation to evaluate statistical significance. 
 
In contrast with burden tests, the sequence kernel association test (SKAT) [Wu et al., 
2011] is a flexible and computationally efficient regression-based approach for rare 
44 
 
 
genetic variants analysis. No assumptions about the directions of effects or the effect 
sizes of rare genetic variants in the region are required for SKAT. Instead of requiring 
permutation for the p-value computation, Davies’ method [Davies, 1980] is used to 
compute the p-values analytically for SKAT. SKAT has been shown to be much more 
powerful than traditional burden tests in many different scenarios. SKAT can be used in 
the association analysis of both dichotomous and continuous phenotypes. 
 
Family-based study designs have been widely used in linkage analysis of diseases and 
quantitative traits [Falk and Rubinstein, 1987; Ott, 1989; Terwilliger and Ott, 1992; 
Spielman, McGinnis and Ewens, 1993]. In GWAS, ordinary regression approaches are 
not applicable to family data, because inflated type I error is observed when familial 
correlation is not appropriately modeled. For quantitative traits, instead of ordinary linear 
regressions, linear mixed effects models that take familial correlation as a random effect 
with covariance proportional to the kinship matrix is commonly used for single marker 
tests in GWAS [Amos, 1994; Almasy and Blangero, 1998; Pankratz, de Andrade and 
Therneau, 2005]. However, burden tests and other methods for joint analysis of rare 
genetic variants in family samples have not been well established. 
 
In this chapter, we use the framework of linear mixed effects models to extend SKAT for 
rare genetic variants association analysis with quantitative traits in family data. The 
family-sample SKAT (famSKAT) has a different form of test statistic and distribution 
under the null hypothesis, but has the same underlying principle as SKAT. When there is 
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no familial correlation, famSKAT is equivalent to SKAT. P-values for famSKAT are also 
calculated analytically without requiring permutation. 
 
We demonstrate in our simulation studies that SKAT has inflated type I error in family 
samples when familial correlation is not appropriately considered. By contrast, famSKAT 
does not suffer from this issue and has correct type I error. We also show that famSKAT 
is more powerful than applying SKAT to an unrelated subset of the sample. For mixed 
datasets with both unrelated and related individuals, as the proportion of unrelated 
individuals decreases, the difference in power between SKAT and famSKAT increases, 
with famSKAT being always the more powerful approach of the two. Thus, by using 
famSKAT there is no need to reduce sample size by selecting an unrelated subset of 
individuals. Finally, we illustrate our approach by assessing the association between rare 
genetic variants using glycemic traits in the Framingham Heart Study. 
 
3.2   Burden Test for Quantitative Traits in Family Samples 
Assuming a sample size of  , let the     vector of the quantitative trait   follow a 
linear mixed effects model 
               
where   is an     covariate matrix,   is a     vector consisting of fixed effects 
parameters (an intercept and     coefficients for covariates),   is an     genotype 
matrix for   rare genetic variants of interest,  is the pre-specified diagonal weight 
matrix for the rare variants of    ,   is a     vector   ,   is an     vector for the 
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random effects of familial correlation, and   is an     vector for the error. The vector 
of error   and the random effects   are assumed normally distributed and uncorrelated 
with each other: 
        
      
        
       
where  is twice the kinship matrix of size     obtained from family information only, 
  
 ,   
  are corresponding variance component parameters. In this parameter setting, we 
are interested in testing         versus        . This is a burden test, because we 
implicitly assume that all rare variants in this test share the same effect size (after 
weighting). 
 
3.3   Sequence Kernel Association Test for Quantitative Traits in Family Samples 
We follow the same notations as in Section 3.2, but now   is a     vector for the 
random effects of rare variants. The vector of error   and the random effects   and   are 
assumed normally distributed and uncorrelated with each other: 
             
        
      
        
       
where  ,   
 ,   
  are corresponding variance component parameters. In this parameter 
setting, we are interested in testing         versus        , which is equivalent to 
testing         versus        . This is a variance component score test in the linear 
mixed effects model, which is a locally most powerful test [Wu et al., 2011; Lin, 1997].  
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Under these assumptions, the phenotypic variance can be written as 
                 
     
        
The log likelihood for the linear mixed effects model is 
    
 
 
       
 
 
                   
To derive a score test for        , we first take the derivative with respect to   to get 
  
  
  
 
 
             
 
 
                           
If we use the restricted maximum likelihood instead of the maximum likelihood method, 
we would get a different first term, but the same second term. In both cases, if we replace 
  by its consistent estimator, and treat genotype matrix   as fixed, then the first term in 
the score function is fixed and independent of phenotype data  . Following the same 
rationale used in the derivation of the SKAT score statistic [Liu, Lin and Ghosh, 2007; 
Kwee et al., 2008], we take twice the second term to be derived as our test statistic. 
 
Under the null hypothesis    , we can estimate 
      
      
      
            
  
        
by fitting the null linear mixed effects model 
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The maximum likelihood estimators can be obtained using the function lmekin from R 
package kinship. We replace ,   
  and   
  (and hence  ) by their maximum likelihood 
estimators and take 
                               
as the famSKAT test statistic. Under the null hypothesis, the variance of the residuals is 
                        
  
        
Thus 
         
 
 
   
 
where    are the eigenvalues of the matrix     
      
     . The p-value can be 
computed analytically by Davies’ method [Davies, 1980] or Kuonen’s saddlepoint 
method [Kuonen, 1999]. 
 
3.3.1 Connection with SKAT in Unrelated Individuals 
We note that even though the null model, test statistic, residual variance and null 
distribution of famSKAT have different forms compared to those of SKAT, they are 
directly connected. Actually, if we add a restriction   
    to the model, famSKAT is 
equivalent to SKAT. Then 
      
      
where    
  is estimated from the null linear model 
         
and famSKAT statistic becomes 
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with distribution under the null hypothesis 
         
 
 
   
 
where    are the eigenvalues of the matrix    
          . The famSKAT statistic and 
its null distribution matrix are proportional to SKAT statistic and null distribution matrix 
with the coefficient    
  . We favor this form of null distribution matrix, rather than the 
form proposed in Wu et al. [2011], because usually the sample size   is larger than the 
number of genetic variants of interest  , the non-zero eigenvalues of        and 
  
 
        
 
  are the same, but the first matrix is of size    , while the second matrix 
is of size    . 
 
3.3.2 Reparametrization 
We note that famSKAT can also be used when we want to provide a known heritability 
coefficient    externally, rather than estimating it from the data. By the reparametrization 
   
  
 
  
    
    
     
    
    
when    is known, we can use the generalized least square method to estimate only    
under the null model. Then we can follow the rest of the famSKAT procedure to perform 
the test. 
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3.4   Simulation Studies 
3.4.1 Type I Error 
3.4.1.1 Simulation Design 
To evaluate the type I error, we performed several simulation studies under the null 
hypothesis of no genetic association. We compared four approaches: famSKAT, family-
sample burden test (famBT), unrelated-sample SKAT (unrSKAT) which only takes the 
unrelated subset of the sample, and SKAT. We used Kuonen’s saddlepoint method 
[Kuonen, 1999] to compute the p-values for famSKAT, unrSKAT and SKAT. 
 
We set the heritability of the trait 
   
  
 
  
    
        
For each parameter setting, we simulated 100 genotype datasets with a total sample size 
of 1000 and 20 single nucleotide polymorphisms (SNP) with minor allele frequency 
(MAF) in the founders randomly sampled from a uniform distribution of 0.005 to 0.05, 
and with low (     ), moderate (     ), or high (     ) linkage disequilibrium 
(LD) between adjacent SNPs in the founders. The correlation between farther SNPs 
decays as an autoregressive model with order 1. We simulated haplotypes for unrelated 
founders with desired MAF and LD structure using the same procedure as HapSim 
[Montana, 2005], then we passed down the haplotypes to the next generation to simulate 
sib pairs, and took the remaining founders as unrelated individuals. Thus we created 
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genotype datasets mixed with unrelated individuals and sib pairs, and let the proportion 
of unrelated individuals decrease from 75% to 50%, 25%, 0%. For each genotype dataset, 
10,000 phenotype datasets including covariates were simulated by using the model 
                     
where     is a vector of continuous values generated from a normal distribution with 
mean 50 and standard deviation 5,     is a vector of dichotomous values generated from 
a Bernoulli distribution with probability 0.5,   follows a multivariate normal distribution 
with means 0 and covariance matrix  , where 
                 
We calculated the p-values of famSKAT, famBT, unrSKAT and SKAT using the Wu 
weights [Wu et al., 2011], corresponding to the square of a beta density function of the 
observed MAF in the founders with parameters 1 and 25. We computed the empirical 
type I error at   levels of 0.01, 0.001 and 0.0001 by counting the proportion of p-values 
less than or equal to the corresponding   level in the 1 million genotype-phenotype 
datasets. 
 
3.4.1.2 Simulation Results 
Table 3.1 shows the empirical type I errors of famSKAT, famBT, unrSKAT and SKAT at 
different   levels in 3 LD scenarios and 4 scenarios for the proportion of unrelated 
individuals. The results suggest that when SKAT is directly applied to the full sample 
with correlated individuals, it has inflated type I error at all   levels. The empirical type I 
error tends to be higher when LD decays. In contrast, famSKAT, famBT and unrSKAT 
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retain the correct type I errors. Thus, in subsequent power simulations we only 
investigated these three approaches. The distributions of the p-values from the four 
approaches for the scenario of LD between adjacent SNPs       and proportion of 
unrelated individuals 0% are shown in Figure 3.1. We found that famSKAT, famBT and 
unrSKAT all had uniform distribution of the p-values, while the distribution of the p-
values from SKAT was more likely to be small, explaining the inflated type I error. 
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Figure 3.1   Distribution of null p-values of famSKAT, famBT, unrSKAT and SKAT 
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Table 3.1   Type I errors of famSKAT, famBT, unrSKAT and SKAT 
LD Unrelated%   level famSKAT famBT unrSKAT SKAT 
r = 0.1 0% 0.01 0.00970 0.01005 0.00871 0.02734 
  0.001 0.00096 0.00100 0.00080 0.00383 
  0.0001 0.00009 0.00009 0.00008 0.00052 
 25% 0.01 0.00963 0.01026 0.00893 0.02168 
  0.001 0.00090 0.00106 0.00078 0.00279 
  0.0001 0.00009 0.00012 0.00008 0.00036 
 50% 0.01 0.00954 0.01007 0.00901 0.01685 
  0.001 0.00094 0.00101 0.00087 0.00200 
  0.0001 0.00009 0.00009 0.00008 0.00024 
 75% 0.01 0.00965 0.01034 0.00935 0.01276 
  0.001 0.00089 0.00107 0.00088 0.00133 
  0.0001 0.00009 0.00012 0.00009 0.00016 
r = 0.5 0% 0.01 0.00998 0.00999 0.00966 0.01991 
  0.001 0.00097 0.00101 0.00088 0.00244 
  0.0001 0.00008 0.00008 0.00009 0.00029 
 25% 0.01 0.01003 0.01011 0.00975 0.01699 
  0.001 0.00097 0.00099 0.00092 0.00202 
  0.0001 0.00010 0.00011 0.00008 0.00025 
 50% 0.01 0.00999 0.01005 0.00982 0.01439 
  0.001 0.00096 0.00103 0.00095 0.00161 
  0.0001 0.00009 0.00011 0.00009 0.00018 
 75% 0.01 0.01012 0.01008 0.00991 0.01200 
  0.001 0.00098 0.00101 0.00094 0.00124 
  0.0001 0.00009 0.00011 0.00009 0.00013 
r = 0.7 0% 0.01 0.00984 0.01003 0.00968 0.01687 
  0.001 0.00092 0.00106 0.00092 0.00197 
  0.0001 0.00010 0.00011 0.00009 0.00025 
 25% 0.01 0.00972 0.00997 0.00962 0.01471 
  0.001 0.00091 0.00099 0.00087 0.00171 
  0.0001 0.00010 0.00011 0.00007 0.00019 
 50% 0.01 0.00978 0.01002 0.00952 0.01290 
  0.001 0.00092 0.00101 0.00092 0.00139 
  0.0001 0.00009 0.00009 0.00010 0.00015 
 75% 0.01 0.00997 0.01009 0.00989 0.01161 
  0.001 0.00096 0.00101 0.00094 0.00120 
  0.0001 0.00011 0.00011 0.00009 0.00013 
Empirical type I errors were calculated as the proportion of p-values less than or equal to 
the corresponding   level in 1 million genotype-phenotype datasets. 
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3.4.2 Power 
3.4.2.1 Simulation Design 
To evaluate the power of famSKAT, famBT and unrSKAT, we set the heritability of 
phenotype        and LD between adjacent SNPs in the founders      , and 
performed simulations under different scenarios. For each parameter setting, we 
simulated 100 genotype datasets with a total sample size 1000 and 20 SNPs with MAF in 
the founders randomly sampled from a uniform distribution of 0.005 to 0.05. Similar to 
the null simulation setting, we simulated genotype datasets mixed with unrelated 
individuals and sib pairs, and changed the proportion of unrelated individuals from 75% 
to 50%, 25%, 0%. For each genotype dataset  , 10,000 phenotype datasets including 
covariates were simulated by using the model 
                        
where    ,     and   are generated in the same way as in the type I error simulations,   
is a vector consisting of the effect sizes of the causal SNPs. We varied the proportion of 
causal SNPs from 20% to 50% and 80%, and we simulated both same and opposite 
directions of effects. Causal SNPs were randomly selected out of the 20 SNPs for each 
phenotype replicate, and in each parameter setting the effect sizes of causal SNPs were 
determined by 
    
 
             
   
where     is the MAF used to generate the genotype dataset for causal SNP  , and   is 
a constant for all causal SNPs in each phenotype replicate, calculated as 
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where   , the total proportion of variance explained by all causal SNPs, was fixed at 1% 
for scenarios when all causal SNPs had effects in the same direction, and 5% for 
scenarios when 50% of the causal SNPs had positive effects and 50% had negative 
effects.   is the LD correlation matrix for the 20 SNPs, and   is a vector indicating the 
directions of causal SNP effects in each replicate. We used the same weights for 
famSKAT, unrSKAT and famBT, which were the Wu weights calculated from the 
observed MAF in founders. The empirical power was evaluated at the   level of 0.001. 
 
3.4.2.2 Simulation Results 
Power simulation results of famSKAT, famBT and unrSKAT are shown in Figure 3.2. In 
all scenarios, 20 SNPs were analyzed. We simulated scenarios in which the proportion of 
causal SNPs was 20%, 50% or 80%, with effects in the same or opposite directions. As 
the proportion of unrelated individuals decreases from 75% to 50%, 25% and 0%, the 
sample size for unrSKAT also decreases from 875 to 750, 625 and 500, respectively. As a 
result, the power of unrSKAT also drops. In contrast, the power of famSKAT and famBT 
remains almost constant, regardless of the proportion of unrelated individuals. FamBT 
has higher power than famSKAT when the proportion of causal SNPs is greater than or 
equal to 50% and all causal SNPs have the same direction of effects, but it has almost no 
power in scenarios when causal SNPs have opposite directions of effects. Generally, 
famSKAT performs well in all these scenarios, suggesting that famSKAT is an omnibus 
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method which does not have compromised power for different mixtures of related and 
unrelated individuals. 
 
 
 
 
Figure 3.2   Power comparisons of famSKAT, famBT and unrSKAT 
 
Empirical power calculated at   level of 0.001. The sample consists of sib pairs and 
unrelated individuals. The total sample size in each scenario is 1000, and the total number 
of SNPs analyzed is 20. In each panel, +/-/0 indicates the proportion of SNPs with 
positive effects, negative effects and no effects. 
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3.5   Analysis of Framingham Heart Study Data 
3.5.1 Candidate Gene Study 
We used genotype data from Framingham SNP Health Association Resource (SHARe) 
and phenotype data from the Framingham Heart Study to analyze the association with 
two glycemic traits: fasting glucose and log-transformed fasting insulin. We restricted our 
analyses to SNPs with MAF less than 5% within 100kb of 16 gene regions selected for 
their prior association with fasting glucose, and 2 genes reported to be associated with 
log-transformed fasting insulin [Dupuis et al., 2010]. We adjusted the fasting glucose 
analysis for age and sex, and log-transformed insulin was additionally adjusted for body 
mass index (BMI). We performed famSKAT and famBT for all individuals with both 
genotype and phenotype available, and performed SKAT for only a subset of unrelated 
individuals. For comparison purpose, we calculated the MAF using a subset of unrelated 
individuals and used Wu weights for all three methods. 
 
We investigated the association between fasting glucose and rare genetic variants in 16 
gene regions previously shown to be associated in large scale GWAS [Dupuis et al., 
2010]: ADCY5, ADRA2A, C2CD4B, CRY2, DGKB-AGMO, FADS1, G6PC2, GCK, 
GCKR, GLIS3, MADD, MTNR1B, PROX1, SLC2A2, SLC30A8, and TCF7L2. The results 
are shown in Table 3.2 and Table 3.3. After adjusting for multiple testing using a 
Bonferroni correction, we detected no association between fasting glucose and rare 
genetic variants in the selected gene regions at the family-wise   level of 0.05, for all 
three methods. CRY2 reaches the nominal significance level with a p-value of 0.0381 
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using famSKAT and 0.0085 using famBT, and G6PC2 reaches the nominal significance 
level with a p-value of 0.0418 using famSKAT, but none of these gene regions reaches 
nominal statistical significance when evaluated using unrSKAT. 
 
We also investigated the association between log-transformed fasting insulin and rare 
genetic variants in 2 gene regions previously shown to be associated in large scale 
GWAS [Dupuis et al., 2010]: GCKR and IGF1. After adjusting for multiple testing using 
a Bonferroni correction, IGF1 shows association with log transformed fasting insulin 
with a nominal p-value of 0.0232 using famSKAT and 0.0234 using famBT. Neither gene 
reaches even the nominal significance level using SKAT. 
 
Tables 3.2 and 3.3 also show that the sample size for unrSKAT is much smaller than that 
for famSKAT and famBT, because there are many families in the study even though the 
Framingham Heart Study is not a family-based cohort. Thus, by selecting unrelated 
individuals we greatly reduced the sample size. Because some SNPs with rare minor 
alleles may not be polymorphic in the subset of unrelated individuals, for some gene 
regions the number of SNPs for unrSKAT is smaller than the number of SNPs for 
famSKAT and famBT. 
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Table 3.2   Candidate gene study results from unrSKAT 
    unrSKAT 
Gene Chr Start Stop 
Sample 
Size 
N 
SNPs 
p-
value 
Trait: fasting glucose 
ADCY5 3 124486089 124650082 1924 17 0.9698 
ADRA2A 10 112826911 112830560 1924 5 0.7293 
C2CD4B 15 60243029 60244774 1924 3 0.7104 
CRY2 11 45825533 45861375 1924 7 0.7299 
DGKB-AGMO 7 14153770 15568165 1924 72 0.1992 
FADS1 11 61323677 61340886 1924 5 0.7049 
G6PC2 2 169465996 169474756 1924 22 0.1373 
GCK 7 44150395 44165412 1924 4 0.2486 
GCKR 2 27573210 27600054 1924 6 0.0930 
GLIS3 9 3814128 4290035 1924 56 0.9822 
MADD 11 47247775 47308158 1924 7 0.6316 
MTNR1B 11 92342437 92355596 1924 11 0.0833 
PROX1 1 212228483 212276385 1924 33 0.1082 
SLC2A2 3 172196831 172227462 1924 5 0.6836 
SLC30A8 8 118216518 118258134 1924 12 0.7869 
TCF7L2 10 114699999 114916060 1924 7 0.2147 
Trait: log-transformed fasting insulin 
GCKR 2 27573210 27600054 1840 6 0.1016 
IGF1 12 101335584 101398508 1840 16 0.1258 
Association analysis with fasting glucose and log-transformed fasting insulin from the 
Framingham Heart Study and genotype data from the Framingham SNP Health 
Association Resource, using unrSKAT. Fasting glucose was adjusted for age and sex, and 
log-transformed fasting insulin was adjusted for age, sex and body mass index. SNPs 
with MAF less than 5% within 100kb of each gene region were included in the analysis. 
Gene and SNP locations were reported on National Center for Biotechnology Information 
(NCBI) build 36. Only a subset of unrelated participants with available genotypes and 
phenotype were analyzed using unrSKAT. Wu weights with beta (1, 25) based on the 
MAF in a subset of unrelated individuals were used. 
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Table 3.3   Candidate gene study results from famSKAT and famBT 
 famSKAT famBT 
Gene 
Sample 
Size 
N 
SNPs 
p-
value 
Sample 
Size 
N 
SNPs 
p-
value 
Trait: fasting glucose 
ADCY5 6479 18 0.9125 6479 18 0.5842 
ADRA2A 6479 5 0.9557 6479 5 0.9453 
C2CD4B 6479 3 0.9576 6479 3 0.8209 
CRY2 6479 8 0.0381 6479 8 0.0085 
DGKB-AGMO 6479 76 0.6579 6479 76 0.3648 
FADS1 6479 5 0.5245 6479 5 0.3723 
G6PC2 6479 24 0.0418 6479 24 0.1173 
GCK 6479 4 0.6283 6479 4 0.5864 
GCKR 6479 7 0.2603 6479 7 0.2461 
GLIS3 6479 57 0.9170 6479 57 0.3920 
MADD 6479 7 0.6571 6479 7 0.5145 
MTNR1B 6479 11 0.8384 6479 11 0.7243 
PROX1 6479 34 0.2414 6479 34 0.3976 
SLC2A2 6479 5 0.8383 6479 5 0.7365 
SLC30A8 6479 12 0.1766 6479 12 0.0970 
TCF7L2 6479 7 0.1035 6479 7 0.4249 
Trait: log-transformed fasting insulin 
GCKR 6031 7 0.4878 6031 7 0.1586 
IGF1 6031 16 0.0232 6031 16 0.0234 
Association analysis with fasting glucose and log-transformed fasting insulin from the 
Framingham Heart Study and genotype data from the Framingham SNP Health 
Association Resource, using famSKAT and famBT. Fasting glucose was adjusted for age 
and sex, and log-transformed fasting insulin was adjusted for age, sex and body mass 
index. SNPs with MAF less than 5% within 100kb of each gene region were included in 
the analysis. All individuals with available genotypes and phenotype were analyzed with 
famSKAT and famBT. Wu weights with beta (1, 25) based on the MAF in a subset of 
unrelated individuals were used. 
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3.5.2 Sliding Window Analysis 
We also performed a genome-wide sliding window analysis on these two traits, as well as 
log-transformed homeostatic model assessment for insulin resistance (HOMA-IR) and 
homeostatic model assessment for β-cell function (HOMA-B), using SHARe genotype 
data. We only included SNPs with MAF less than 5% and ran the analysis using a sliding 
window of 500kb, with 250kb overlap each with previous and subsequent windows. We 
removed windows with 0 or 1 SNP, resulting in 10,546 windows for all autosomes with 
the number of SNPs ranging from 2 to 76 with a median of 18. No window reached the 
genome-wide significance using famSKAT, famBT or unrSKAT. The Quantile-Quantile 
plots for famSKAT are shown in Figure 3.3. There is minimal inflation of the p-values 
from this genome-wide analysis. 
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Figure 3.3   Quantile-Quantile plots for famSKAT in the genome-wide sliding window 
analysis on four glycemic traits 
 
The p-values were plotted as minus log base 10 p-values. The genomic control (GC) 
factor     was computed as the ratio of median chi-square statistics with 1 df 
corresponding to observed and expected p-values. 
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3.6   Computation Time 
The computation time of famSKAT depends on both the sample size and the number of 
SNPs. The empirical run time of famSKAT, famBT and SKAT in analyzing sib pairs 
with indicated total sample sizes on a single computing node with 2.33 GHz central 
processing unit (CPU) and 4 GB memory is shown in Figure 3.4. With a small sample 
size, the limiting step in famSKAT is fitting the null linear mixed effects model, so the 
computation time is comparable to that of famBT, which also requires fitting a linear 
mixed effects model. As the sample size increases, all three methods require more 
computation time, and the time of famSKAT and SKAT increases dramatically. Both 
famSKAT and SKAT require matrix calculation, and the limiting step in famSKAT 
becomes inverting the matrix   , which takes about 90% of the computation time when 
the sample size is 5000. The genome-wide sliding window analysis of SHARe genotype 
data using a sliding window of 500kb takes about 5 hours for chromosome 1 on a single 
computing node with 2.33 GHz CPU and 4 GB memory. 
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Figure 3.4   Run time of famSKAT, famBT and SKAT in analyzing 20 SNPs 
 
 
 
3.7   Discussion 
In this chapter, we propose famSKAT as an extension of SKAT which can be applied to 
data with familial correlation. We demonstrate that famSKAT is a general and flexible 
variance component score test approach, which is equivalent to SKAT when the familial 
variance component is set to 0. It can be applied to quantitative traits with unknown or 
known heritability. 
 
Compared with famBT, famSKAT is advantageous in power when the proportion of 
causal SNPs in a genomic region is small, and when not all causal SNPs have the same 
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direction of effects. As expected, famBT outperforms famSKAT when the proportion of 
causal SNPs is greater than or equal to 50% and all these SNPs have positive effects, but 
the performance of famSKAT in these scenarios is still satisfactory. In real data analysis, 
when we do not have sufficient a priori information about the proportion of causal SNPs 
or the directions of effects, famSKAT would be a better choice over famBT. 
 
We show that when SKAT is inappropriately applied to correlated data, it has inflated 
type I error. Thus, the best we can do for SKAT is to select unrelated individuals from the 
whole sample. However, our power simulations demonstrate that this strategy reduces 
power in many scenarios. In contrast, we do not need to reduce our sample size if we use 
famSKAT. Our real data example from the Framingham Heart Study also shows that 
SKAT does not even have an observation which reaches the nominal significance level of 
0.05. 
 
Common genetic variants at 16 gene regions chosen for fasting glucose and 2 gene 
regions chosen for log-transformed fasting insulin have been shown to be associated with 
either trait in large GWAS [Dupuis et al., 2010]. However, we do not have solid evidence 
to show that there is strong association between either trait and the rare genetic variants 
in these regions. We noticed that the sample size in this analysis was far smaller than in 
Dupuis et al. [2010], which reduced power. In addition, the SHARe project was not 
specifically designed for rare variants analysis, so most SNPs in our genotype dataset are 
common SNPs and were excluded from the analysis. With the progress of sequencing 
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studies, we should be able to identify many more rare variants and perform a candidate 
gene or even genome-wide analysis again using the new genotype dataset with dense rare 
genetic variants. On the other hand, some gene regions may be truly associated with the 
trait only through common SNPs, so we do not expect to identify the association with 
rare genetic variants for all these gene regions we selected. 
 
With the development in sequencing technology and decreasing cost, sequencing data 
which contain a lot of rare genetic variants have become available, not only for case-
control studies, but also for cohorts that include family members. Based on SKAT, one of 
the most powerful rare genetic variants analysis methods to date, we developed 
famSKAT in the hope of facilitating rare genetic variants analysis to identify novel genes 
associated with quantitative traits. With famSKAT, cohorts with family data can perform 
the association analysis with rare genetic variants, using as much data as possible, 
without having to select unrelated individuals from the pedigree. 
 
For calculating the p-values, we recommend using Kuonen’s saddlepoint method 
[Kuonen, 1999] instead of Davies’ method [Davies, 1980]. As a method based on 
numerical integration, Davies’ method requires specifying the accuracy. When the p-
value is expected to be very small, Davies’ method cannot calculate it accurately. Table 
3.4 shows this numerical issue in a power simulation context. Davies’ method suffers 
from negative and zero p-values (and possibly significant round-off error) regardless of 
the accuracy specified. In contrast, Kuonen’s method does not have such issues. Thus, if 
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we perform a genome-wide rare variants analysis using sequence data, from which we 
expect extreme low p-values, Kuonen’s method is a better choice than Davies’ method. 
 
Even though famSKAT was developed for analyzing rare genetic variants, it can also be 
used for common variant analysis, combined common and rare variant analysis or 
conditional association analyses. Depending on the research hypothesis, common variants 
can be treated as fixed effects in the model, or random effects along with the rare genetic 
variants. Recently, Schifano et al. [2012] developed a SNP set association analysis 
approach for common variants analysis in family data, which is essentially equivalent to 
our method. The use of famSKAT combined with the collapsing of some very rare 
genetic variants such as singletons is also possible. Similar with SKAT, external weights 
based on annotation information or functional prediction can be incorporated to further 
boost power. 
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Table 3.4   Comparison of Kuonen’s and Davies’ methods in calculating p-values in the 
tail 
Method Accuracy 
Minimum 
p-value 
Median 
p-value 
Maximum 
p-value 
% p-
value  
< 0 
% p-
value 
 = 0 
% 
round-
off 
error
$ 
Kuonen NA 1.2×10
-23 
2.1×10
-9
 0.021 0% 0% 0% 
Davies 10
-4 –1.2×10-6 0 0.022 0.87% 83.31% 0% 
 10
-5 –5.6×10-7 0 0.022 6.04% 71.37% 0% 
 10
-6 –3.1×10-8 0 0.022 12.14% 54.32% 0% 
 10
-7 –4.4×10-9 0 0.022 16.38% 38.19% 0% 
 10
-8 –2.4×10-9 0 0.022 27.65% 23.15% 0% 
 10
-9 –2.0×10-10 1.8×10-9 0.022 21.41% 14.86% 0% 
 10
-10 –3.3×10-11 1.9×10-9 0.022 17.89% 9.23% 0% 
 10
-11 –5.7×10-13 1.9×10-9 0.022 7.64% 5.38% 0% 
 10
-12 –9.7×10-14 1.9×10-9 0.022 5.93% 2.93% 0% 
 10
-13 –2.4×10-14 1.9×10-9 0.022 4.79% 1.53% 0% 
 10
-14 –4.4×10-16 1.9×10-9 0.022 0.01% 0.89% 20.34% 
 10
-15 –2.9×10-15 1.9×10-9 0.022 1.40% 0.58% 99.67% 
$
 Proportion of significant round-off error in the calculation, returned by the function 
davies from R package CompQuadForm. Using our power simulation framework, we 
simulated a scenario with phenotype heritability    equal to 0.5, LD between adjacent 
SNPs in the founders   set to 0.5. We simulated 500 sib pairs and 20 SNPs with founders’ 
MAF randomly sampled from a uniform distribution of 0.005 to 0.05. Of these 20 SNPs, 
16 were neutral and 4 were positively associated with the trait, explaining 5% of the 
phenotypic variance in total. We analyzed 10000 replicates using famSKAT with 
Kuonen’s method, and Davies’ method with accuracy from 10-4 to 10-15. 
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Chapter 4 Methods for Rare Genetic Variants Analysis in Detecting Gene by 
Environment Interaction on Quantitative Traits 
 
4.1   Introduction 
Traditional genome-wide association studies (GWAS) have been successfully applied to 
identify a large number of genetic markers associated with complex diseases and related 
quantitative traits. However, for most complex diseases and quantitative traits, all genetic 
markers identified so far only explain a small proportion of heritability in these traits, 
suggesting that a lot of genetic determinants are still undiscovered. The most commonly 
used approach in traditional GWAS is the single marker test of common genetic variants. 
Eichler et al. [2010] suggested that gene by environment interaction and rare genetic 
variants may both account for some of the unexplained heritability. 
 
Statistical methods for detecting gene by environment interaction have been well 
established in the context of common genetic variants [Kraft et al., 2007; Manning et al., 
2011]. To determine if a common genetic variant interacts with an environmental 
variable, which is also included in the regression model as a covariate, we can either 
assess the interaction term alone, or jointly test both the genetic main effect and gene by 
environment interaction terms. By using the first approach, we are usually interested in 
testing the gene by environment interaction, regardless of the presence of a significant 
genetic main effect. However, by using the second approach, we are testing if the genetic 
marker is associated with the trait of interest, allowing for gene by environmental 
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covariate interaction. These methods combined with multivariate meta-analysis have led 
to the discovery of novel common loci associated with fasting insulin [Manning et al., 
2012]. 
 
On the other hand, rare genetic variants analysis has become a popular research field in 
genetic association studies, and many statistical methods for rare variants analysis have 
been proposed [Han and Pan, 2010; Hoffmann, Marini and Witte, 2010; Li and Leal, 
2008; Madsen and Browning, 2009; Morgenthaler and Thilly, 2007; Morris and Zeggini, 
2010; Wu et al., 2011]. Of these methods, SKAT [Wu et al., 2011] has been shown as 
one of the most powerful approach in various scenarios. However, all of these methods 
focus on the main effect association analysis of rare genetic variants. 
 
Compared with common variants analysis, rare variants analysis often requires a larger 
sample size to attain comparable power. Compared with main effect analysis, interaction 
analysis also needs a larger sample size. Thus, little attention has been paid to interaction 
analysis for rare genetic variants, possibly due to the limited sample size in many cohort 
studies. 
 
In this chapter, we propose a general approach for testing gene by environment 
interaction on quantitative traits in a SKAT framework. We start from 3 ways to obtain 
residuals from the null model, and show that 2 of them are equivalent. We compare our 
two approaches with a burden test of the interaction term in simulation studies, and we 
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also illustrate our approaches in testing gene by BMI interaction on fasting glucose, 
adjusting for age and sex, using an unrelated subset of individuals from the Framingham 
Heart Study. 
 
4.2   Burden Test for Gene-Environment Interaction 
Assuming a sample size of  , let the     vector of the quantitative trait   follow a 
linear model 
                  
where   is an     covariate matrix,   is a     vector consisting of fixed effects 
parameters for covariates (an intercept and     coefficients for covariates),   is an 
    genotype matrix for   rare genetic variants of interest,  is a     pre-specified 
diagonal weight matrix for the rare variants,   is a     vector for the main effect of rare 
variants,   is an     diagonal matrix with elements the environmental variable of 
interest, which is included in   as a column, with mean 0,   is a     vector for the SNP 
by environment interaction effect, and it is equal to   , and   is an     vector for the 
error. The vector of error   follows 
        
       
where   
  is the variance parameter. In this parameter setting, we are interested in testing 
        versus        . This is a burden test, because we implicitly assume that all 
rare variants in this test share the same interaction effect size (after weighting). 
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4.3   Sequence Kernel Association Test for Gene-Environment Interaction 
We follow the same notations as in Section 4.2, but now   is a     vector for the 
random effects of gene-environment interaction. The vector of error   and the random 
effects   are assumed normally distributed and uncorrelated with each other: 
        
       
        
       
where   
  and   
  are corresponding variance component parameters. We are interested in 
testing       
    versus       
   , which is equivalent to testing         versus 
       . Here we propose 3 ways to obtain the residuals from the null model 
             
 
4.3.1 Fixed Main Effects 
For the first approach to obtain residuals, we treat the genotype main effects    as fixed 
effects, and fit the null model as a linear regression model with covariates and genotype 
main effects. We fit the null linear regression model 
             
and obtain estimates   ,  ,    
 . Under the null hypothesis of no interaction, the test 
statistic 
                 
 
                      
follows a weighted sum of   
  distribution 
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where    are the eigenvalues of the matrix 
        
                  
            
where                  is the combined matrix for covariates and weighted 
genotypes. In this chapter, we denote this approach as SKAT-FIX. 
 
4.3.2 Random Main Effects with Residuals Adjusting for Covariates Only 
In our second approach, we assume a linear mixed effects model 
                  
where random genotype main effects         
    . We also assume that   is 
uncorrelated with random effects for the interaction   and error  . We obtain estimates   , 
   
 ,    
  by fitting the null linear mixed effects model 
             
Under the null hypothesis of no interaction, the test statistic 
             
 
                          
follows a weighted sum of   
  distribution 
            
 
 
   
 
where    are the eigenvalues of the matrix 
       
                                     
where       
          
   . In this chapter, we denote this approach as SKAT-RAN. 
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4.3.3 Random Main Effects with Residuals Adjusting for Genotype Main Effects 
For the third approach, we fit the same null model as in Section 4.3.2, but instead of 
using residuals      , we now use residuals          , where   is estimated 
random effects for the genotype main effects. The difference is that in Section 4.3.2, we 
consider the genotype main effects in the matrix    through the parameter estimate    
 . 
Now we have adjusted the genotype main effects in the residuals, the test statistic 
becomes 
                  
 
                      
Given the fact that 
                        
      
      
                
we have 
                   
                   
        
                    
     
      
             
thus 
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This test statistic is proportional to SKAT-RAN test statistic we derive in Section 4.3.2. 
In this chapter, we do not consider it as a different approach, and we do not include it in 
simulation studies or real data analysis. 
 
4.4   Extension to Related Individuals 
The methods described in Sections 4.2 and 4.3 are only applicable to unrelated 
individuals. However, some cohort studies include related individuals. In this section, we 
discuss the extension of burden test and SKAT in testing gene-environment interaction to 
related individuals with known family structure. 
 
4.4.1 Burden Test 
In samples with related individuals, our revised model is a linear mixed effects model 
                    
where   is an     vector of the quantitative trait,   is an     covariate matrix,   is a 
    vector consisting of fixed effects parameters for covariates (an intercept and     
coefficients for covariates),   is an     genotype matrix for   rare genetic variants of 
interest,  is a     pre-specified diagonal weight matrix for the rare variants,   is a 
    vector for the main effect of rare variants,   is an     diagonal matrix with the 
environmental variable of interest, which has mean 0 and is included in   as a column,   
is a     vector for the SNP by environment interaction effect, and it is equal to   ,  is 
an     vector for the random effects of familial correlation, and   is an     vector for 
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the error. The vector of error   and the random effects  are assumed normally 
distributed and uncorrelated with each other: 
        
      
        
       
where  is twice the kinship matrix of size     obtained from family information only, 
  
 ,   
  are corresponding variance component parameters. In this parameter setting, we 
are interested in testing         versus        . This is a test for a fixed effect 
parameter in a linear mixed effects model. 
 
4.4.2 SKAT with Fixed Main Effects 
We follow the same notations as in Section 4.4.1, but now   is a     vector for the 
random effects of gene-environment interaction. The vector of error   and the random 
effects   and  are assumed normally distributed and uncorrelated with each other: 
        
       
        
      
        
       
where   
 ,   
  and   
  are corresponding variance component parameters. We are 
interested in testing       
    versus       
   , which is equivalent to testing 
        versus        . We first fit the null linear mixed effects model 
               
and obtain estimates   ,  ,    
 ,    
 . We define 
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Under the null hypothesis of no interaction, the test statistic 
                 
 
                              
follows a weighted sum of   
  distribution 
            
 
 
   
 
where    are the eigenvalues of the matrix 
       
                                         
where                  is the combined matrix for covariates and weighted 
genotypes. 
 
4.4.3 SKAT with Random Main Effects 
We follow the same notations as in Section 4.4.2, and in addition, we assume   is a     
vector for the random effects of genotype main effects. The vector of error   and the 
random effects  ,   and  are assumed normally distributed and uncorrelated with each 
other: 
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where   
 ,   
 ,   
  and   
  are corresponding variance component parameters. We are 
interested in testing       
    versus       
   , which is equivalent to testing 
        versus        . We first fit the null linear mixed effects model 
               
and obtain estimates   ,    
 ,    
 ,    
 . We define 
      
          
      
     
Under the null hypothesis of no interaction, the test statistic 
             
 
                          
follows a weighted sum of   
  distribution 
            
 
 
   
 
where    are the eigenvalues of the matrix 
       
                      
  
             
 
It is easy to show that for related individuals, if we adjust for the genotype main effects 
and use a      type of test statistic, as we describe for unrelated individuals in Section 
4.3.3, we would get exactly the same test statistic as     . 
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4.5   Simulation Studies 
4.5.1 Type I Error 
4.5.1.1 Simulation Design 
To evaluate the performance of the burden test and two SKAT approaches in detecting 
gene-environment interaction, we first performed two null simulation studies: 1. The trait 
is not associated with the genotypes; 2. The trait is associated with the genotypes but 
there is no interaction effects. For each scenario, we simulated 100 genotype datasets 
with 2000 unrelated individuals and 20 single nucleotide polymorphisms (SNP) with 
minor allele frequency (MAF) randomly sampled from a uniform distribution of 0.005 to 
0.05, and with low (     ), moderate (     ), high (     ) linkage disequilibrium 
(LD) between adjacent SNPs. The correlation between farther SNPs decays as an 
autoregressive model with order 1. In the first null simulation study, for each genotype 
dataset, 1000 phenotype datasets including covariates were simulated from 
                            
where     is a vector of continuous covariate generated from a normal distribution with 
mean 50 and standard deviation 5,     is a vector of dichotomous covariate generated 
from a Bernoulli distribution with probability 0.5,     is a vector of continuous 
covariate generated from a normal distribution with mean 25 and standard deviation 4,   
is independent and identically distributed standard normal random error. 
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In the second null simulation study, genotype datasets were generated the same way as in 
the first study, but we fixed LD between adjacent SNPs to be      . For each genotype 
dataset, 1000 phenotype datasets were simulated from 
                               
where    ,    ,     and   were generated in the same way as before,   is a vector 
consisting of the effect sizes of the causal SNPs. We varied the proportion of causal SNPs 
from 20% to 50% and 80%, and we simulated both same and opposite directions of main 
effects. Causal SNPs were randomly selected out of the 20 SNPs for each phenotype 
replicate, and in each parameter setting the effect sizes of causal SNPs were determined 
by 
    
 
             
   
where     is the MAF used to generate the genotype dataset for causal SNP  , and   is 
a constant for all causal SNPs in each phenotype replicate, calculated as 
  
  
    
   
where   , the total proportion of variance explained by all causal SNPs, was fixed at 1% 
for scenarios when all causal SNPs had main effects in the same direction, and 5% for 
scenarios when 50% of the causal SNPs had positive main effects and 50% had negative 
main effects.   is the LD correlation matrix for the 20 SNPs, and   is a vector indicating 
the directions of causal SNP effects in each replicate. 
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In both null simulation studies, we tested gene by BMI interaction. We used Wu weights 
for all three approaches. 
 
4.5.1.2 Simulation Results 
Table 4.1 shows the empirical type I errors from 100,000 replicates in the first null 
simulation study without genotype main effects, using the burden test (BT), SKAT-FIX 
and SKAT-RAN for gene by BMI interaction. At the   levels of 0.05, 0.01 and 0.001, all 
three methods have correct type I errors. The conclusion is consistent regardless of the 
LD structure in the genotype data. The Quantile-Quantile plots from the first null 
simulation study without genotype main effects are shown in Figure 4.1. In all 3 
scenarios, the p-values from BT, SKAT-FIX and SKAT-RAN are all very close to the 
expected uniform distribution on the interval (0, 1). 
 
Table 4.2 shows the empirical type I errors from 100,000 replicates in the second null 
simulation study with genotype main effects, using BT, SKAT-FIX and SKAT-RAN for 
gene by BMI interaction. At all three   levels of 0.05, 0.01 and 0.001, we did not observe 
strong evidence for inflated type I errors, for any of the three methods. The results 
suggest that the conclusion does not depend on the proportion of causal markers with 
main effects, or the proportion of protective and detrimental genetic markers. Figure 4.2 
shows the Quantile-Quantile plots from the second null simulation with genotype main 
effects in the same direction, and Figure 4.3 shows the Quantile-Quantile plots from the 
second null simulation with genotype main effects in different directions. In all 6 
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scenarios, the p-values from BT, SKAT-FIX and SKAT-RAN are all very close to the 
expected uniform distribution on the interval (0, 1). 
 
Results from both simulation studies suggest that all three methods are valid in type I 
errors in various scenarios, with or without genotype main effects. 
 
 
 
 
 
 
 
 
Table 4.1   Type I errors from the null simulation without genotype main effects 
LD   level BT SKAT-FIX SKAT-RAN 
r = 0.1 0.05 0.0503 0.0497 0.0496 
 0.01 0.0097 0.0100 0.0098 
 0.001 0.0009 0.0010 0.0010 
r = 0.5 0.05 0.0498 0.0509 0.0498 
 0.01 0.0097 0.0102 0.0101 
 0.001 0.0010 0.0011 0.0010 
r = 0.7 0.05 0.0506 0.0519 0.0505 
 0.01 0.0100 0.0097 0.0096 
 0.001 0.0010 0.0009 0.0008 
Empirical type I errors were calculated as the proportion of p-values less than or equal to 
the corresponding   level in 100,000 genotype-phenotype datasets. 
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Table 4.2   Type I errors from the null simulation with genotype main effects 
Causal markers   level BT SKAT-FIX SKAT-RAN 
+/-/0 = 4/0/16 0.05 0.0502 0.0507 0.0500 
 0.01 0.0100 0.0096 0.0096 
 0.001 0.0007 0.0009 0.0009 
+/-/0 = 10/0/10 0.05 0.0502 0.0508 0.0503 
 0.01 0.0103 0.0100 0.0099 
 0.001 0.0010 0.0011 0.0011 
+/-/0 = 16/0/4 0.05 0.0501 0.0513 0.0509 
 0.01 0.0098 0.0104 0.0099 
 0.001 0.0010 0.0008 0.0008 
+/-/0 = 2/2/16 0.05 0.0497 0.0501 0.0506 
 0.01 0.0097 0.0098 0.0098 
 0.001 0.0009 0.0010 0.0010 
+/-/0 = 5/5/10 0.05 0.0496 0.0512 0.0511 
 0.01 0.0097 0.0104 0.0105 
 0.001 0.0010 0.0008 0.0009 
+/-/0 = 8/8/4 0.05 0.0511 0.0516 0.0518 
 0.01 0.0105 0.0103 0.0099 
 0.001 0.0009 0.0009 0.0009 
Empirical type I errors were calculated as the proportion of p-values less than or equal to 
the corresponding   level in 100,000 genotype-phenotype datasets. +/-/0 denote the 
number of causal markers with positive and negative effects, and neutral markers. 
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Figure 4.1   Quantile-Quantile plots from the null simulation without genotype main 
effects 
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Figure 4.2   Quantile-Quantile plots from the null simulation with genotype main effects 
in the same direction 
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Figure 4.3   Quantile-Quantile plots from the null simulation with genotype main effects 
in different directions 
 
 
4.5.2 Power 
4.5.2.1 Simulation Design 
To evaluate the power of the burden test and two SKAT approaches in detecting gene-
environment interaction, we performed two simulation studies under the alternative 
hypothesis: 1. There is gene by BMI interaction; 2. There is gene by sex interaction. We 
investigated the performance of the three approaches in detecting gene by environmental 
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variable interaction using both continuous and dichotomous environmental variables. For 
each scenario, we simulated 100 genotype datasets with 2000 unrelated individuals and 
20 SNPs with MAF randomly sampled from a uniform distribution of 0.005 to 0.05, and 
we fixed LD between adjacent SNPs to be      . 
 
In the first simulation study of gene by BMI interaction, for each genotype dataset, 1000 
phenotype datasets were simulated from 
                                          
where    ,    ,     and   were generated in the same way as in the null simulation 
studies,   was determined using the same method as in the second null simulation study 
with genotype main effects. We varied the proportion of causal SNPs from 20% to 50% 
and 80%, and we simulated both same and opposite directions of main effects. We also 
simulated both same and opposite directions of interaction effects. Causal SNPs were 
randomly selected out of the 20 SNPs for each phenotype replicate, and in each 
parameter setting the interaction effect sizes of causal SNPs were determined by 
    
 
                     
   
where     is the MAF used to generate the genotype dataset for causal SNP  , and   is 
a constant for all causal SNPs in each phenotype replicate, calculated as 
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where   , the total proportion of variance explained by gene by BMI interaction, was 
fixed at 1% for scenarios when all causal SNPs had interaction effects in the same 
direction, and 5% for scenarios when 50% of the causal SNPs had positive interaction 
effects and 50% had negative interaction effects.  is the LD correlation matrix for the 
20 SNPs, and   is a vector indicating the directions of causal SNP interaction effects in 
each replicate. We tested gene by BMI interaction and used Wu weights for all three 
approaches. 
 
In the second simulation study of gene by sex interaction, for each genotype dataset, 1000 
phenotype datasets were simulated from 
                                           
where    ,    ,    ,   and   were generated in the same way as in the first simulation 
study of gene by BMI interaction. We varied the proportion of causal SNPs from 20% to 
50% and 80%, and we simulated both same and opposite directions of main effects. We 
also simulated both same and opposite directions of interaction effects. Causal SNPs 
were randomly selected out of the 20 SNPs for each phenotype replicate, and in each 
parameter setting the interaction effect sizes of causal SNPs were determined by 
    
 
                     
   
where     is the MAF used to generate the genotype dataset for causal SNP  , and   is 
a constant for all causal SNPs in each phenotype replicate, calculated as 
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where   ,  and   were determined in the same way as in the first simulation study of 
gene by BMI interaction. We tested gene by sex interaction and used Wu weights for all 
three approaches. 
 
4.5.2.2 Simulation Results 
Figure 4.4 shows the power results from the first simulation study of gene by BMI 
interaction. Empirical power was calculated at the significance level of 10
-5
. Figure 4.4 
suggests that the direction of main effects   almost has no effect on power. When the 
proportions of causal markers with positive interaction effects, negative interaction 
effects, and neutral markers are fixed, the power remains almost the same no matter 
whether the causal markers have the same or different directions of main effects. The 
burden test has the highest power when the proportion of causal markers is large and all 
causal markers have interaction effects in the same direction. However, it has almost no 
power when causal markers have interaction effects in different directions, which 
matches our expectation. The SKAT-type tests are most powerful when the proportion of 
causal markers is small, or when causal markers have interaction effects in different 
directions. SKAT-RAN has slightly higher power than SKAT-FIX in all scenarios, but 
the difference in power is trivial. 
 
Figure 4.5 shows the power results from the second simulation study of gene by sex 
interaction, at the significance level of 10
-5
. The results are consistent with Figure 4.4, 
91 
 
 
suggesting that each of these methods performs similarly when analyzing gene by 
continuous covariate interaction and gene by dichotomous covariate interaction. 
Generally, the SKAT-type tests perform well in all the scenarios, and the performance of 
each test greatly depends on the proportions of positive, negative and neutral interaction 
effects  , but not the proportions of positive, negative and neutral main effects  . 
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Figure 4.4   Power comparisons of SKAT-FIX, SKAT-RAN and BT in detecting gene by 
BMI interaction 
 
Empirical power calculated at   level of 10-5. In each scenario, +/-/0 indicates the number 
of SNPs with positive effects, negative effects and no effects.   denotes SNP main effects, 
and   denotes SNP by BMI interaction effects. 
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Figure 4.5   Power comparisons of SKAT-FIX, SKAT-RAN and BT in detecting gene by 
sex interaction 
 
Empirical power calculated at   level of 10-5. In each scenario, +/-/0 indicates the number 
of SNPs with positive effects, negative effects and no effects.   denotes SNP main effects, 
and   denotes SNP by sex interaction effects. 
 
4.6   Application 
We performed a genome-wide sliding window analysis to detect gene by BMI interaction 
on fasting glucose, using SHARe genotype data. We analyzed an unrelated subset of 
individuals, with total sample size 1921. We selected SNPs with MAF less than 5% and 
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ran the analysis using a sliding window of 500kb, with 250kb overlap each with previous 
and subsequent windows. We removed windows with 0 or 1 SNP, resulting in 10,538 
windows for all autosomes with the number of SNPs ranging from 2 to 74 with median 
18. No window reached the genome-wide significance using SKAT-FIX, SKAT-RAN or 
BT. The Quantile-Quantile plots for SKAT-FIX and SKAT-RAN are shown in Figure 4.6. 
There is no inflation of the p-values from this genome-wide analysis. 
 
 
 
Figure 4.6   Quantile-Quantile plots for SKAT-type tests in the genome-wide sliding 
window analysis for gene by BMI interaction on fasting glucose 
 
The p-values were plotted as minus log base 10 p-values. The genomic control factor     
was computed as the ratio of median chi-square statistics with 1 df corresponding to 
observed and expected p-values. 
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4.7   Discussion 
In this chapter, we propose two SKAT-type tests for detecting gene by environment 
interaction. Depending on whether to adjust for genotype main effects as fixed or random 
effects, the two tests are named SKAT-FIX and SKAT-RAN, respectively. We 
demonstrate that both of them are flexible and powerful tests on the gene by environment 
interaction effects, in the context of rare genetic variants analysis. When the number of 
rare variants in the test is large, we recommend SKAT-RAN over SKAT-FIX, not only 
because it has slightly higher power in general, but also because fitting a multiple linear 
regression model with a lot of predictors in SKAT-FIX may not be a good way to obtain 
residuals. 
 
Compared with burden tests on the interaction effects, SKAT-type tests have higher 
power when the proportion of causal genetic markers in a genomic region is small, or 
when causal genetic markers have different directions of gene by environment interaction 
effects. Although the burden test performs better than SKAT-type tests when the 
proportion of causal genetic markers is greater than or equal to 50% and all these markers 
have the same direction of gene by environment interaction effects, SKAT-type tests do 
not suffer from a great power loss in these scenarios. In addition, external weights based 
on gene annotation and biological functional prediction can be incorporated to further 
increase the statistical power. 
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We did not find any gene by BMI interaction on fasting glucose in a genome-wide sliding 
window analysis using SHARe genotype data, at the genome-wide significance level. 
Since the SHARe project was not designed for rare variants analysis, most SNPs in our 
genotype dataset are common genetic markers with MAF greater than 5%, which were 
excluded from the analysis. With decreasing sequencing cost, we should be able to revisit 
our real data example in the future when more rare genetic variants are identified in the 
Framingham Heart Study. 
 
In this chapter, we also derive the test statistics and null distributions of the two SKAT-
type tests in analyzing related individuals, as an extension of famSKAT in Chapter 3 to 
tests for gene by environment interaction. When we have related individuals in our 
dataset, we do not need to exclude some of them to obtain an unrelated subset to perform 
the analysis. We have shown in Chapter 3 that selecting unrelated individuals suffers 
from power loss due to sample size reduction in the context of genotype main effects rare 
variants analysis, compared with famSKAT. We believe the situation is similar in gene 
by environment interaction tests. By using famSKAT-type tests, we do not have to reduce 
the sample size, and it is easy to see that famSKAT-type tests in Section 4.4 are the same 
as their corresponding SKAT-type equivalent in Section 4.3 when all individuals are 
unrelated. 
 
We note that although the SKAT-type tests are generally powerful in many scenarios, 
they are not optimal in some cases. SKAT assumes that the genotype random effects of 
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rare variants have mean 0. When the true mean is not 0, the power may be compromised, 
compared with burden tests. Wang, Chen and Yang [2012] proposed different approaches, 
allowing for non-zero mean, and jointly tested the mean and the variance component. 
They showed in extensive simulation studies that their approaches outperform SKAT in 
many simulation scenarios. In the context of gene by environment interaction tests, we 
can also allow for non-zero means of interaction random effects  , and jointly test the 
mean and variance component parameters. When adjusting for genotype main effects   
in SKAT-RAN, instead of         
    , we can also assume          
     and 
estimate   from the null model. Lee, Wu and Lin [2012] dealt with the power loss of 
SKAT compared to burden tests in some scenarios and proposed a hybrid of SKAT and 
burden tests named SKAT-O. They showed that SKAT-O is better than SKAT when the 
proportion of causal genetic variants is large and all causal variants have the same 
direction of effects. We can use the same idea and derive SKAT-O-type tests for gene by 
environment interaction, which may improve the performance in some scenarios. 
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Chapter 5 Summary and Future Work 
 
5.1   Summary 
Genetic association studies have been of great interest in statistical genetics for years. 
However, for complex diseases and quantitative traits, all associated genetic variants 
identified so far only explain a small proportion of the heritability. We believe that the 
hunting for novel genetic variants accounting for the unexplained heritability is essential 
in fully explaining the disease etiology, and that novel statistical methods are strongly 
needed in this field. 
 
In this dissertation, we propose general and specific statistical approaches which can be 
applied in genetic association studies. In Chapter 2, we develop a method of moments 
estimator for the between-study covariance matrix in random effects model multivariate 
meta-analysis. We hope this approach will facilitate random effects model multivariate 
meta-analysis in various scientific fields including statistical genetics and address the 
heterogeneity issue in the fixed effects model, described in Section 1.3. In Chapter 3, we 
extend SKAT to be applicable to rare genetic variants analysis on quantitative traits in 
family samples. We start from a general powerful and computationally efficient approach 
in rare genetic variants analysis for unrelated individuals, SKAT, introduced in Section 
1.4, and modify it using the same strategy as for related individuals in single marker 
GWAS, linear mixed effects models, discussed in Section 1.2. In Chapter 4, we derive 
two interaction-only SKAT-type tests for both unrelated and related individuals, which 
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combines the ideas in Sections 1.4 and 1.5, and Section 1.2. Together, we hope these 
novel methods will advance genetic association studies (Section 1.1), and other scientific 
fields in which meta-analysis, correlated data analysis, sparse data analysis, or interaction 
analysis are applicable. 
 
5.2   Future Work 
5.2.1 Extension of the Method of Moments Estimator 
Meta-regression is a regression based meta-analysis approach to investigate whether 
particular covariates explain any of the heterogeneity of effects between studies 
[Thompson and Higgins, 2002]. Similar to meta-analysis, meta-regression includes both 
fixed effects model and random effects model, and it can be either univariate or 
multivariate. Without loss of generality, we assume a random effects meta-regression 
model which takes a similar notation to the random effects meta-analysis model in 
Section 2.3: 
                                
where   is the number of studies,   is the number of effect sizes,   is the number of 
regression parameters (including the intercept) for each effect size, which satisfies    . 
We can see clearly that if    , then the model only has an intercept for each effect size, 
and is equivalent to the meta-analysis model. In the meta-regression context, it is not 
difficult to develop a similar method of moments estimator for the between-study 
covariance matrix. 
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Ma and Mazumdar [2011] proposed a nonparametric and non-iterative method to 
estimate the between-study covariance matrix in random effects model multivariate meta-
analysis, based on the theory of U-statistic. However, similar to the method proposed by 
Jackson, White and Thompson [2010], their approach also requires matching each 
element of the between-study covariance matrix separately, which may not be invariant 
to reparametrization of effect sizes. Thus, a matrix form estimator based on the theory of 
U-statistic, with invariance property to linear transformation, may be desirable in this 
field. 
 
5.2.2 Sequence Kernel Association Test for Dichotomous Traits in Family Samples 
The original SKAT approach for unrelated individuals is a powerful and flexible method 
which can be applied to both quantitative and dichotomous traits, although the 
distribution of the test statistic under the null hypothesis is different for quantitative and 
dichotomous phenotypes. Our extended approach to related individuals, however, 
currently only applies to quantitative traits. The major problem is that although we can 
model the familial correlation as a random effect in the linear mixed effects model when 
analyzing quantitative traits, the variance-covariance structure for dichotomous traits is 
different. The situation is complicated if we apply a generalized linear mixed effects 
model in the analysis and treat the familial correlation as a random effect, because the 
link function is no longer the identity link, and we are likely to mis-specify the 
covariance structure after transformation. 
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The issue is not specific to SKAT in family samples. It also exists for single marker tests 
on dichotomous traits. Usually we use the generalized estimating equations with 
independent variance structure to perform single marker tests. Using the same strategy, in 
SKAT we can also fit the null model without any genetic effects, but incorporating 
familial correlation. After deriving the covariance matrix for the residuals from the null 
model, we can develop a test statistic and its null distribution. However, the performance 
in terms of type I error and power needs further investigation. 
 
5.2.3 Joint Test of Genetic Main Effects and Gene by Environment Interaction for 
Rare Genetic Variants 
In Chapter 4 we develop two SKAT-type interaction-only tests for gene by environment 
interaction in rare genetic variants analysis. As discussed in Section 1.5, research 
questions addressed by interaction-only tests and joint tests are different. If we focus on 
testing whether there is association with any rare genetic variants, allowing for gene by 
environment interaction, then a joint test may be desirable. Following the same notation 
as in Section 4.3.2, we assume a linear mixed effects model 
                  
where random genotype main effects         
    , and gene by environment 
interaction random effects         
    . Although we can assume the same weights  
in genotype main effects and interaction effects, generally we cannot assume that the 
variance component parameters   
  and   
  are the same. In this model, a joint test would 
test the hypotheses       
    
    versus       
    or   
   . We note that when 
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   , the test       
    versus       
   , and when   
   , the test       
    
versus       
    both follow a SKAT-type weighted sum of   
  distribution in curved 
parameter spaces. However, since the joint test lies in the parameter space 
    
    
      
      
    , the test statistic and its null distribution need further 
investigation. 
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Appendices 
 
Appendix A   Derivation of the Method of Moments Estimator 
Let 
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Under the heterogeneity hypothesis 
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Assuming that any two studies are independent, then for     
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It follows that 
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Let 
     
                  
 
 
   
             
then 
            
If we transpose it, we also have 
             
then 
  
          
 
      
  is symmetric. Throughout this dissertation, we assume that the covariance matrix    is 
positive definite for all  . Otherwise if one or more covariance matrices have at least one 
eigenvalue of 0, the determinant of   would be 0, making it not invertible. 
When all    are positive definite, all   
   are also positive definite,   
    , so 
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and  is positive definite. A symmetric method of moments estimator for   is 
   
         
 
   
 
 
 
 
108 
 
 
Bibliography 
Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. 
American Journal of Human Genetics 1998; 62: 1198-1211. 
 
Amos CI. Robust variance-components approach for assessing genetic linkage in 
pedigrees. American Journal of Human Genetics 1994; 54: 535-543. 
 
Becker BJ, Wu M. The synthesis of regression slopes in meta-analysis. Statistical Science 
2007; 22: 414-429. 
 
Berkey CS, Hoaglin DC, Antczak-Bouckoms A, Mosteller F, Colditz GA. Meta-analysis 
of multiple outcomes by regression with random effects. Statistics in Medicine 1998; 17: 
2537-2550. 
 
Chen H, Manning AK, Dupuis J. A method of moments estimator for random effect 
multivariate meta-analysis. Biometrics 2012; 68: 1278-1284. 
 
Chen H, Meigs JB, Dupuis J. Sequence kernel association test for quantitative traits in 
family samples. Genetic Epidemiology 2013; 37: 196-204. 
 
Cohn LD, Becker BJ. How meta-analysis increases statistical power. Psychological 
Methods 2003; 8: 243-253. 
109 
 
 
 
Davies RB. The distribution of a linear combination of chi-square random variables. 
Journal of the Royal Statistical Society: Series C (Applied Statistics) 1980; 29: 323-333. 
 
Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the 
EM algorithm. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 
1977; 39: 1-38. 
 
DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 
7: 177-188. 
 
Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting 
glucose homeostasis and their impact on type 2 diabetes risk. Nature Genetics 2010; 
42:105-116.  
 
Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH. Missing 
heritability and strategies for finding the underlying causes of complex disease. Nature 
Reviews Genetics 2010; 11: 446-450.  
 
Falk CT, Rubinstein P. Haplotype relative risks: an easy reliable way to construct a 
proper control sample for risk calculations. Annals of Human Genetics 1987; 51: 227-233.  
 
110 
 
 
Fisher RA. Statistical methods for research workers (4th edition) 1932; Edinburgh: 
Oliver and Boyd. 
 
Follmann DA, Proschan MA. Valid inference in random effects meta-analysis. 
Biometrics 1999; 55: 732-737. 
 
Han F, Pan W. A data-adaptive sum test for disease association with multiple common or 
rare variants. Human Heredity 2010; 70: 42-54. 
 
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in 
Medicine 2002; 21: 1539-1558. 
 
Hoffmann TJ, Marini NJ, Witte JS. Comprehensive approach to analyzing rare genetic 
variants. PLoS One 2010; 5: e13584.  
 
Ingels SJ, Pratt DJ, Herget DR, Burns LJ, Dever JA, Ottem R, Rogers JE, Jin Y, 
Leinwand S. High School Longitudinal Study of 2009 (HSLS:09). Base-Year Data File 
Documentation (NCES 2011-328) 2011; U.S. Department of Education, Washington, DC: 
National Center for Education Statistics. Retrieved Nov. 16, 2011 from 
http://nces.ed.gov/pubsearch. 
 
111 
 
 
Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology 
to perform multivariate random effects meta-analyses. Statistics in Medicine 2010; 29: 
1282-1297. 
 
Jennrich RI, Schluchter MD. Unbalanced repeated-measures models with structured 
covariance matrices. Biometrics 1986; 42: 805-820. 
 
Kraft P, Yen YC, Stram DO, Morrison J, Gauderman WJ. Exploiting gene-environment 
interaction to detect genetic associations. Human Heredity 2007; 63: 111-119. 
 
Kuonen D. Saddlepoint approximations for distributions of quadratic forms in normal 
variables. Biometrika 1999; 86: 929-935. 
 
Kwee LC, Liu D, Lin X, Ghosh D, Epstein MP. A powerful and flexible multilocus 
association test for quantitative traits. American Journal of Human Genetics 2008; 82: 
386-397. 
 
Lee S, Wu MC, Lin X. Optimal tests for rare variant effects in sequencing association 
studies. Biostatistics 2012; 13: 762-775. 
 
112 
 
 
Li B, Leal SM. Methods for detecting associations with rare variants for common 
diseases: application to analysis of sequence data. American Journal of Human Genetics 
2008; 83:311-321.  
 
Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. 
Biometrika 1986; 73: 13-22. 
 
Lin DY, Zeng D. Meta-analysis of genome-wide association studies: no efficiency gain in 
using individual participant data. Genetic Epidemiology 2010; 34: 60-66. 
 
Lin X. Variance component testing in generalised linear models with random effects. 
Biometrika 1997; 84: 309-326. 
 
Lindgren CM, Heid IM, Randall JC, et al. Genome-wide association scan meta-analysis 
identifies three loci influencing adiposity and fat distribution. PLoS Genetics 2009; 5: 
e1000508. 
 
Lipták T. On the combination of independent tests. Magyar Tudományos Akadémia 
Matematikai Kutató Intézetének Közleményei 1958; 3: 171-197. 
 
113 
 
 
Liu D, Lin X, Ghosh D. Semiparametric regression of multidimensional genetic pathway 
data: least-squares kernel machines and linear mixed models. Biometrics 2007; 63: 1079-
1088. 
 
Ma Y, Mazumdar M. Multivariate meta-analysis: a robust approach based on the theory 
of U-statistic. Statistics in Medicine 2011; 30: 2911-2929. 
 
Madsen BE, Browning SR. A groupwise association test for rare mutations using a 
weighted sum statistic. PLoS Genetics 2009; 5: e1000384.  
 
Manning AK, Hivert MF, Scott RA, et al. A genome-wide approach accounting for body 
mass index identifies genetic variants influencing fasting glycemic traits and insulin 
resistance. Nature Genetics 2012; 44: 659-669. 
 
Manning AK, LaValley M, Liu CT, et al. Meta-analysis of gene-environment interaction: 
joint estimation of SNP and SNP x environment regression coefficients. Genetic 
Epidemiology 2011; 35: 11-18. 
 
McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn 
JN. Genome-wide association studies for complex traits: consensus, uncertainty and 
challenges. Nature Reviews Genetics 2008; 9: 356-369. 
 
114 
 
 
Montana G. HapSim: a simulation tool for generating haplotype data with pre-specified 
allele frequencies and LD coefficients. Bioinformatics 2005; 21: 4309-4311. 
 
Morgenthaler S, Thilly WG. A strategy to discover genes that carry multi-allelic or 
mono-allelic risk for common diseases: a cohort allelic sums test (CAST). Mutation 
Research 2007; 615: 28-56. 
 
Morris AP, Zeggini E. An evaluation of statistical approaches to rare variant analysis in 
genetic association studies. Genetic Epidemiology 2010; 34: 188-193.  
 
Ott J. Statistical properties of the haplotype relative risk. Genetic Epidemiology 1989; 6: 
127-130.  
 
Pankratz VS, de Andrade M, Therneau TM. Random effects Cox proportional hazard 
model: general variance components methods for time-to-event data. Genetic 
Epidemiology 2005; 28: 97-109. 
 
Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting 
glucose levels. Nature Genetics 2009; 41: 77-81. 
 
Psaty BM, O’Donnell CJ, Gudnason V, et al. Cohorts for Heart and Aging Research in 
Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of 
115 
 
 
genome-wide association studies from 5 cohorts. Circulation: Cardiovascular 
Genetics 2009; 2: 73-80. 
 
Raudenbush SW, Becker BJ, Kalaian H. Modeling multivariate effect sizes. 
Psychological Bulletin 1988; 103: 111-120. 
 
Riley RD, Abrams KR, Lambert PC, Sutton AJ, Thompson JR. An evaluation of bivariate 
random-effects meta-analysis for the joint synthesis of two correlated outcomes. Statistics 
in Medicine 2007; 26: 78-97. 
 
Schifano ED, Epstein MP, Bielak LF, Jhun MA, Kardia SLR, Peyser PA, Lin X. SNP set 
association analysis for familial data. Genetic Epidemiology 2012; 36: 797-810. 
 
Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the 
insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal 
of Human Genetics 1993; 52: 506-516.  
 
Stouffer SA, Suchman EA, DeVinney LC, Star SA, Williams RM Jr. The American 
soldier: adjustment during army life (Vol. 1) 1949; Princeton: Princeton University Press. 
 
Terwilliger JD, Ott J. A haplotype-based 'haplotype relative risk' approach to detecting 
allelic associations. Human Heredity 1992; 42: 337-346.  
116 
 
 
 
Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and 
interpreted? Statistics in Medicine 2002; 21: 1559-1573. 
 
van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: 
multivariate approach and meta-regression. Statistics in Medicine 2002; 21: 589-624. 
 
Wang Y, Chen YH, Yang Q. Joint rare variant association test of the average and 
individual effects for sequencing studies. PLoS One 2012; 7: e32485. 
 
Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. Rare-variant association testing for 
sequencing data with the sequence kernel association test. American Journal of Human 
Genetics 2011; 89: 82-93. 
 
Zeggini E, Scott LJ, Saxena R, et al. Meta-analysis of genome-wide association data and 
large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nature 
Genetics 2008; 40: 638-645. 
 
 
 
 
 
117 
 
Curriculum Vitae 
118 
 
 
119 
 
120 
 
121 
 
 
122 
 
 
 
